<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63509</article-id><article-id pub-id-type="doi">10.7554/eLife.63509</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Activation of MAP3K DLK and LZK in Purkinje cells causes rapid and slow degeneration depending on signaling strength</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-209825"><name><surname>Li</surname><given-names>Yunbo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3222-858X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209826"><name><surname>Ritchie</surname><given-names>Erin M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209827"><name><surname>Steinke</surname><given-names>Christopher L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1663-9971</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209828"><name><surname>Qi</surname><given-names>Cai</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" id="author-209829"><name><surname>Chen</surname><given-names>Lizhen</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">‡</xref></contrib><contrib contrib-type="author" id="author-209830"><name><surname>Zheng</surname><given-names>Binhai</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-6322"><name><surname>Jin</surname><given-names>Yishi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9371-9860</contrib-id><email>yijin@ucsd.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Neurobiology Section, Division of Biological Sciences, University of California San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Neurosciences, School of Medicine, University of California San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>VA San Diego Healthcare System</institution><addr-line><named-content content-type="city">San Diego</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Kavli Institute of Brain and Mind, University of California San Diego</institution><addr-line><named-content content-type="city">La Jolla</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Orr</surname><given-names>Harry T</given-names></name><role>Reviewing Editor</role><aff><institution>University of Minnesota</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution>Fred Hutchinson Cancer Research Center</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p> Department of Human Genetics, and the Grossman Institute for Neuroscience, Quantitative Biology and Human Behavior, The University of Chicago, Chicago, United States</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p> Barshop Institute for Longevity and Aging Studies, Department of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, United States</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>21</day><month>01</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e63509</elocation-id><history><date date-type="received" iso-8601-date="2020-09-27"><day>27</day><month>09</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-01-19"><day>19</day><month>01</month><year>2021</year></date></history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63509-v2.pdf"/><abstract><p>The conserved MAP3K Dual-Leucine-Zipper Kinase (DLK) and Leucine-Zipper-bearing Kinase (LZK) can activate JNK via MKK4 or MKK7. These two MAP3Ks share similar biochemical activities and undergo auto-activation upon increased expression. Depending on cell-type and nature of insults DLK and LZK can induce pro-regenerative, pro-apoptotic or pro-degenerative responses, although the mechanistic basis of their action is not well understood. Here, we investigated these two MAP3Ks in cerebellar Purkinje cells using loss- and gain-of function mouse models. While loss of each or both kinases does not cause discernible defects in Purkinje cells, activating DLK causes rapid death and activating LZK leads to slow degeneration. Each kinase induces JNK activation and caspase-mediated apoptosis independent of each other. Significantly, deleting CELF2, which regulates alternative splicing of <italic>Map2k7</italic>, strongly attenuates Purkinje cell degeneration induced by LZK, but not DLK. Thus, controlling the activity levels of DLK and LZK is critical for neuronal survival and health.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Purkinje cells</kwd><kwd>cerebellum</kwd><kwd>DLK</kwd><kwd>LZK</kwd><kwd>Celf2</kwd><kwd>neurodegeneration</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Jin</surname><given-names>Yishi</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005191</institution-id><institution>Craig H. Neilsen Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Jin</surname><given-names>Yishi</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>Kavli Institute for Brain and Mind, University of California San Diego</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Jin</surname><given-names>Yishi</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>Junior Seau Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Jin</surname><given-names>Yishi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The activity levels of two closely related MAPKKK are differentially regulated in Purkinje neuron survival.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Mitogen-activated protein kinase (MAPK) signaling pathways play important roles in neuronal development and function, and aberrant regulation of MAP kinases is associated with many neurological diseases, such as Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD) (<xref ref-type="bibr" rid="bib64">Thomas and Huganir, 2004</xref>; <xref ref-type="bibr" rid="bib53">Schellino et al., 2019</xref>; <xref ref-type="bibr" rid="bib30">Hotamisligil and Davis, 2016</xref>; <xref ref-type="bibr" rid="bib28">Hollville et al., 2019</xref>; <xref ref-type="bibr" rid="bib2">Asghari Adib et al., 2018</xref>). The MAPK cascade involves MAP3Ks (MAP kinase kinase kinases), MAP2Ks and MAPKs that together form a phosphorylation relay and activate downstream signaling events in response to external or internal stimuli. The mammalian MAP3K DLK (Dual leucine zipper kinase, or MAP3K12) and LZK (Leucine zipper kinase, or MAP3K13) are orthologs of <italic>C. elegans</italic> DLK-1 and <italic>Drosophila</italic> DLK/Wallenda (<xref ref-type="bibr" rid="bib37">Jin and Zheng, 2019</xref>). These MAP3Ks act as upstream kinases for JNK and p38 MAP kinase, and are now known as key players in neuronal stress response network both under acute injury and in chronic neurodegenerative diseases (<xref ref-type="bibr" rid="bib63">Tedeschi and Bradke, 2013</xref>; <xref ref-type="bibr" rid="bib37">Jin and Zheng, 2019</xref>; <xref ref-type="bibr" rid="bib2">Asghari Adib et al., 2018</xref>; <xref ref-type="bibr" rid="bib15">Farley and Watkins, 2018</xref>). An emerging theme is that while activation of these kinases triggers seemingly common pathways, the outcome is highly context-specific both in terms of cell types and forms of insults.</p><p>Both DLK and LZK show broad expression in the nervous system. Several studies have investigated roles of DLK in the development of the nervous system. Constitutive DLK knockout mice die perinatally, and different regions of developing brain display varying degrees of altered axon fibers, abnormal synapses and increased neuronal survival (<xref ref-type="bibr" rid="bib25">Hirai et al., 2006</xref>; <xref ref-type="bibr" rid="bib26">Hirai et al., 2011</xref>; <xref ref-type="bibr" rid="bib35">Itoh et al., 2011</xref>; <xref ref-type="bibr" rid="bib54">Sengupta Ghosh et al., 2011</xref>). However, mice with adult deletion of DLK survive and show no detectable abnormalities (<xref ref-type="bibr" rid="bib50">Pozniak et al., 2013</xref>; <xref ref-type="bibr" rid="bib40">Le Pichon et al., 2017</xref>). Under traumatic insults, DLK activity is reported to increase and trigger a variety of cellular responses. For example, sciatic nerve injury induces DLK-dependent pro-regenerative responses in dorsal root ganglia (DRG) sensory neurons (<xref ref-type="bibr" rid="bib55">Shin et al., 2012</xref>; <xref ref-type="bibr" rid="bib56">Shin et al., 2019</xref>). In the CNS, optic nerve injury upregulates DLK expression in retinal ganglion cells (RGC), which triggers cell death and also promotes axon growth from surviving RGCs (<xref ref-type="bibr" rid="bib67">Watkins et al., 2013</xref>; <xref ref-type="bibr" rid="bib68">Welsbie et al., 2013</xref>). In a mouse model for stroke, increased DLK expression in pre-motor cortex is suggested to promote motor recovery (<xref ref-type="bibr" rid="bib38">Joy et al., 2019</xref>). Increased DLK activity is also reported in animal models of neurodegeneration, and genetically or pharmacologically inhibiting DLK in the aged PS2APP mice for AD and the SOD1<sup>G93A</sup> mice for ALS has resulted in some neuroprotective effects (<xref ref-type="bibr" rid="bib40">Le Pichon et al., 2017</xref>). Additionally, in human iPSC derived neurons treated with ApoE4, a protein associated with an increased risk for AD, DLK is rapidly upregulated and enhances transcription of APP (<xref ref-type="bibr" rid="bib31">Huang et al., 2017</xref>). As numerous approaches now target DLK for drug discovery (<xref ref-type="bibr" rid="bib58">Siu et al., 2018</xref>), it is important to investigate how the pleiotropic effects of manipulating DLK in different cell types influence disease progression. In comparison, despite the fact that LZK was also discovered 20 years ago (<xref ref-type="bibr" rid="bib52">Sakuma et al., 1997</xref>), the in vivo roles of LZK are only beginning to be explored. In a mouse model of spinal cord injury, LZK is upregulated in astrocytes and mediates reactive astrogliosis (<xref ref-type="bibr" rid="bib8">Chen et al., 2018</xref>). Emerging studies show that LZK can cooperate with DLK to promote RGC death after optic nerve injury and DRG axon degeneration (<xref ref-type="bibr" rid="bib69">Welsbie et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Summers et al., 2020</xref>).</p><p>Here, we dissect the roles of these two kinases in the cerebellar Purkinje cells. We analyzed genetic deletion mice for each kinase, and also developed transgenic mice that allow for Cre-mediated expression of DLK or LZK. Biochemical studies have shown that DLK and LZK undergo auto-activation via leucine-zipper-mediated dimerization, and such auto-activation is dependent on the protein abundance (<xref ref-type="bibr" rid="bib48">Nihalani et al., 2000</xref>; <xref ref-type="bibr" rid="bib33">Ikeda et al., 2001b</xref>). Therefore, elevating expression of DLK or LZK is a proxy to its activation of the downstream signal transduction. We find that deletion of DLK and/or LZK, singly or in combination, from Purkinje cells, does not affect their development and postnatal growth. In contrast, induced expression of DLK in Purkinje cells causes rapid degeneration, whereas elevating LZK expression induces slow degeneration. Strikingly, we find that deleting the RNA splicing factor CELF2 ameliorates Purkinje cell degeneration induced by LZK, but not DLK, partly via regulating alternative splicing of <italic>Map2k7,</italic> which encodes the MAP2K7/MKK7. These findings provide important insights to the understanding of neurodegenerative processes.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Normal development of cerebellar Purkinje cells in the absence of DLK and LZK</title><p>Both DLK and LZK are expressed in cerebellar neurons, with high levels of DLK observed in the molecular layer of adult cerebellum (<xref ref-type="bibr" rid="bib24">Hirai et al., 2005</xref>; <xref ref-type="bibr" rid="bib59">Suenaga et al., 2006</xref>; <xref ref-type="bibr" rid="bib17">Goodwani et al., 2020</xref>). DLK knockout (KO) mice die soon after birth, and cerebellar architecture is grossly normal (<xref ref-type="bibr" rid="bib25">Hirai et al., 2006</xref>). The roles of LZK in neuronal development remain unknown. To address the function of LZK and further probe into the interactions between the two kinases, we generated an LZK KO mouse line (genotype <italic>Map3k13<sup>KO/KO</sup></italic> ) using CRISPR-editing to delete the entire kinase domain (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–B</xref>), which also resulted in a frameshift and produced no detectable LZK proteins by immunoprecipitation and western blotting analysis (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). The LZK KO mice are viable, and grow indistinguishably from littermates under standard housing conditions. Histological analysis of cerebellar tissue sections using hematoxylin and eosin staining revealed no discernible defects in overall cellular architecture in 2-month-old (P60) LZK KO mice (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Immunostaining using antibodies to Calbindin, which specifically labels Purkinje cells, showed that the position, number and gross morphology of Purkinje cells were comparable between LZK KO and control (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). The molecular layer thickness, which is a sensitive assessment for disruption of the dendrites of Purkinje cells (<xref ref-type="bibr" rid="bib70">White et al., 2014</xref>; <xref ref-type="bibr" rid="bib21">Hansen et al., 2013</xref>), was also normal (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Morphology of cerebellar Purkinje cells is normal in the absence of LZK and DLK.</title><p>(<bold>A</bold>) Histological and immunostaining images of cerebellar sections of P60 mice of genotypes indicated, stained with hematoxylin and eosin (left panel), hematoxylin (enlarged red boxed areas, middle panel) and Calbindin (right panel). <italic>Map3k12 </italic>synonyms for DLK, <italic>Map3k13 </italic>for LZK. Roman letters mark corresponding lobules in the vermis of the cerebellum. Arrows point to the Purkinje cell bodies. Scale bars: 500 μm (left panel), 50 μm (middle panel), 100 μm (right panel). (<bold>B</bold>) Quantification of total number of Purkinje cells in all cerebellar lobules. (<bold>C</bold>) Quantification of cerebellum area, with perimeters measured by outlining the outer edge of midline sagittal sections of the cerebella. (<bold>D</bold>) Quantification of the molecular layer thickness in cerebellar lobules V-VI. (<bold>B–D</bold>) n = 3 animals per genotype, and three sections/animal; data shown as means ± SEM. Statistics: one-way ANOVA; ns. no significant.</p><p> <supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Total number of Purkinje cells in all cerebellar lobules of P60 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig1-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Cerebellum area of P60 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig1-data2-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Molecular layer thickness in cerebellar lobules V-VI of P60 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig1-data3-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Knockout mice lines and associated evidence.</title><p>(<bold>A</bold>) <italic>Map3k13</italic> KO mice were generated by CRISPR-Cas9 technology using three sgRNAs targeted to the kinase domain of LZK. Scale bar: 1 kb. (<bold>B</bold>) The homozygotes or heterozygotes of <italic>Map3k13<sup>KO</sup></italic> were identified by PCR using primers YJ12529-12531. (<bold>C</bold>) The LZK protein levels in cerebellum of P60 mice of genotypes indicated were determined by immunoprecipitation and western blot. (<bold>D</bold>) <italic>Map3k12<sup>fl/fl</sup></italic> mice have loxP sites flanking the exon 4 that contains the initiation ATG codon, and Cre-mediated excision results in knockout of DLK. Scale bar: 1 kb. (<bold>E</bold>) The homozygotes or heterozygotes of <italic>Map3k12<sup>fl</sup></italic> were identified by PCR using primers YJ12523 and YJ12524. (<bold>F</bold>) <italic>Map3k13<sup>fl/fl</sup></italic> mice have loxP sites flanking exon 2, and Cre-mediated excision results in frameshift, hence knockout of LZK. Scale bar: 1 kb. (<bold>G</bold>) The homozygotes or heterozygotes of <italic>Map3k13<sup>fl</sup></italic> were identified by PCR using primers YJ12525 and YJ12526. (<bold>H</bold>) The DLK protein levels in cerebellum of P60 mice of genotypes indicated were determined by western blot. (<bold>I</bold>) Representative images of GFAP staining of cerebellar astrocytes from P60 mice of genotypes indicated. Scale bars: 100 μm. (<bold>J</bold>) GFAP staining intensity is quantified and normalized to <italic>Pvalb<sup>Cre/+</sup></italic> in cerebellum of P60 mice. <italic>Pvalb<sup>Cre/+</sup></italic>: n = 5 animals, three sections/animal; <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup></italic>, <italic>Pvalb<sup>Cre/+</sup>;Map3k13<sup>fl/fl</sup></italic> and <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup>;Map3k13<sup>fl/fl</sup></italic>: n = 3 animals, three sections/animal. MFI: mean of fluorescence intensity. (<bold>K</bold>) Quantification of the body weight of P60 mice of genotypes indicated. Wild-type: n = 8; <italic>Map3k13<sup>KO/KO</sup></italic>: n = 4; <italic>Pvalb<sup>Cre/+</sup></italic>: n = 8; <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup></italic>: n = 8; <italic>Pvalb<sup>Cre/+</sup>;Map3k13<sup>fl/fl</sup></italic>: n = 8; <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup>;Map3k13<sup>fl/fl</sup></italic>: n = 6. (<bold>J, K</bold>) Data shown are means ± SEM; Statistics: one-way ANOVA; ns. no significant.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig1-figsupp1-v2.tif"/></fig></fig-group><p>It has recently been shown that DLK and LZK can act synergistically in injured RGC or DRG neurons (<xref ref-type="bibr" rid="bib69">Welsbie et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Summers et al., 2020</xref>). We therefore tested if loss of both DLK and LZK might affect cerebellar neurons. We bred floxed (<italic>fl</italic>) KO mice for DLK (genotype <italic>Map3k12<sup>fl/fl</sup></italic>) or LZK (genotype <italic>Map3k13<sup>fl/fl</sup>)</italic> to a parvalbumin-Cre driver line (<italic>Pvalb<sup>Cre</sup></italic>) (<xref ref-type="bibr" rid="bib22">Hippenmeyer et al., 2005</xref>). We obtained <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup>;Map3k13<sup>fl/fl</sup></italic> mice, along with <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup></italic> and <italic>Pvalb<sup>Cre/+</sup>; Map3k13<sup>fl/fl</sup></italic> mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D–G</xref>). Cre recombinase from <italic>Pvalb<sup>Cre</sup></italic> line is active in Purkinje cells as early as P4 (<xref ref-type="bibr" rid="bib22">Hippenmeyer et al., 2005</xref>). We detected reduced protein levels of DLK and LZK in cerebellar extracts for <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup>;Map3k13<sup>fl/fl</sup></italic>, <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup></italic> and <italic>Pvalb<sup>Cre/+</sup>;Map3k13<sup>fl/fl</sup></italic> mice, respectively (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C,H</xref>). The overall cerebellar tissue organization, revealed by hematoxylin and eosin staining, was indistinguishable among test and control mice of P60 age (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Calbindin immunostaining showed that the total number of Purkinje cells and the molecular layer thickness of cerebellum were comparable in single or double deletion of each kinase gene (<xref ref-type="fig" rid="fig1">Figure 1A–D</xref>). Additionally, GFAP immunostaining for cerebellar astrocytes revealed no detectable difference among different genotypes of mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1I–J</xref>). All mutant mice also showed normal postnatal growth, measured by body weight, comparable to the control mice under same housing conditions (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K</xref>). These data show that DLK and LZK are not required for the postnatal development of Purkinje cells.</p></sec><sec id="s2-2"><title>Elevating DLK expression in Purkinje cells causes rapid degeneration via apoptosis</title><p>Increased expression of DLK or LZK has been observed under traumatic injury or other stress conditions (<xref ref-type="bibr" rid="bib55">Shin et al., 2012</xref>; <xref ref-type="bibr" rid="bib56">Shin et al., 2019</xref>; <xref ref-type="bibr" rid="bib67">Watkins et al., 2013</xref>; <xref ref-type="bibr" rid="bib68">Welsbie et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Joy et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="bib31">Huang et al., 2017</xref>). We next investigated how elevating expression of DLK and LZK, which would lead to activation of these kinases, affects neurons. To this end, we generated two transgenic mouse lines by inserting a Cre-inducible DLK or LZK cDNA expression construct at the <italic>Hipp11</italic> locus, designated as Hipp11-DLK(iOE) or Hipp11-LZK(iOE), respectively (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>). In each transgene, the induced expression can be readily assessed by a tdTomato reporter fused in-frame to the C-terminus of DLK or LZK through the T2A self-cleaving peptides. By RNA-seq analysis we detected comparable levels of tdTomato mRNAs produced from each transgene following expression of Cre recombinase (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). After outcrossing to C57BL/6J background, these mice were bred to the <italic>Pvalb<sup>Cre</sup></italic> line. In <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ or <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ heterozygous mice, we observed tdTomato reporter expression correlating with the timing of parvalbumin expression (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>), and increased DLK or LZK expression was detected in cerebellar protein lysates (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E–H</xref>).</p><p>Elevated DLK expression in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice caused gross abnormalities noticeable as early as P6. The pups were smaller than littermate controls (<xref ref-type="fig" rid="fig2">Figure 2A–B</xref>), and exhibited abnormal movements (<xref ref-type="video" rid="video1">Video 1</xref>). These pups all died around P21, with cerebella smaller than those of littermate controls (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). Histological analysis of cerebellar tissues revealed grossly abnormal lobular morphology (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). By Calbindin immunostaining, we detected dramatic degeneration of Purkinje cells, with a nearly complete (~98%) cell loss by P21 (<xref ref-type="fig" rid="fig2">Figure 2D–E</xref>). The molecular layer of the cerebellum in these mice was significantly thinner than that in the littermate control mice from P10 to P21 (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Purkinje cell degeneration is known to be associated with increased reactivity of astrocytes and microglia (<xref ref-type="bibr" rid="bib12">Cvetanovic et al., 2015</xref>; <xref ref-type="bibr" rid="bib43">Lobsiger and Cleveland, 2007</xref>; <xref ref-type="bibr" rid="bib39">Lattke et al., 2017</xref>). Indeed, we observed increased expression of GFAP and IBA1 (detecting both microglia and macrophage) in these mice at P21, compared to control mice (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C–F</xref>). Some IBA1-positive microglia were found to be closely associated with tdTomato-labeled Purkinje cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>), suggesting that dying cells might be phagocytosed.</p><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-63509-video1.mp4"><label>Video 1.</label><caption><title>Locomotor deficits in P15 <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-DLK(iOE)/+ mice.</title><p>A representative P15 old <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mouse exhibited difficulty moving forward and drags its abdomen along the ground, as well as tremors.</p></caption></media><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Induced expression of DLK using parvalbumin-cre (<italic>Pvalb<sup>Cre/+</sup></italic>) causes animal growth defects and rapid degeneration of Purkinje cells.</title><p>(<bold>A</bold>) Representative image of P21 pups of genotypes indicated, and pups with induced DLK expression in PV<sup>+</sup> neurons are smaller than siblings. Scale bar: 2 cm. (<bold>B</bold>) Quantification of the body weight from P5 to P21. Hipp11-DLK(iOE)/+: n = 3 (P5), n = 3 (P6), n = 4 (P8), n = 12 (P10), n = 8 (P15) and n = 10 (P21); <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-DLK(iOE)/+: n = 5 (P5), n = 6 (P6), n = 4 (P8), n = 11 (P10), n = 9 (P15) and n = 10 (P21). (<bold>C</bold>) Quantification of the cerebellum area from P5 to P21. (<bold>D</bold>) Representative images of Calbindin staining of cerebellar sections of littermates from mating parents <italic>Pvalb<sup>Cre/+</sup></italic> to Hipp11-DLK(iOE)/+ at indicated postnatal days. Red boxes are enlarged to show that induced expression of DLK causes a total loss of Purkinje cells by P21. Scale bars: 500 μm (upper panels), 100 μm (lower panels). (<bold>E</bold>) Quantification of total number of Purkinje cells in all cerebellar lobules. (<bold>F</bold>) Quantification of the molecular layer thickness in cerebellar lobules V-VI. Color representation for genotypes in C, E, and F is the same as in B. (<bold>C, E, F</bold>) n = 3 animals per genotype, three sections/animal for each time point. (<bold>B–C, E–F</bold>) Data shown as means ± SEM. Statistics: Student’s unpaired t-test; ns, no significant; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p><p> <supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Mouse body weight of genotypes indicated from P5 to P21.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig2-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Mouse cerebellum area of genotypes indicated from P5 to P21.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig2-data2-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Total number of Purkinje cells in all cerebellar lobules of mice genotypes indicated from P5 to P21.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig2-data3-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig2sdata4"><label>Figure 2—source data 4.</label><caption><title>Molecular layer thickness in cerebellar lobules V-VI of mice genotypes indicated from P5 to P21.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig2-data4-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Cre-dependent DLK and LZK expression transgenic mice and associated evidence.</title><p>(<bold>A</bold>) Illustration of Cre-dependent expression of Hipp11-DLK(iOE) and Hipp11-LZK(iOE) transgenic mice, generated following the protocol described previously (<xref ref-type="bibr" rid="bib62">Tasic et al., 2011</xref>). (<bold>B</bold>) PCR genotyping for Hipp11-DLK(iOE) and Hipp11-LZK(iOE) using primers YJ12520-12522. (<bold>C</bold>) Graph shows mRNA levels of tdTomato obtained from RNA-sequencing of cerebellum from P15 mice of Hipp11-DLK(iOE)/+ and Hipp11-LZK(iOE)/+ that expressed Cre in glutamatergic neurons. Transcript per million (TPM) values represent tdTomato transcript counts normalized by gene length and sequencing depth; and statistically significance was based on differential expression analysis using DESeq2 galaxy version 2.11.40.2 (<xref ref-type="bibr" rid="bib44">Love et al., 2014</xref>). (<bold>D</bold>) Representative images of cerebellar sections of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice showing tdTomato expression as induced from Hipp11-DLK(iOE)/+ and immunostained for parvalbumin for Cre at indicated postnatal days. The dotted lines in top panels mark the boundary of anterior zone (AZ; lobules I-V), central zone (CZ; lobules VI-VII), posterior zone (PZ; lobules VIII-XI), and nodular zone (NZ; lobule X) in cerebellum, note higher tdTomato intensity in anterior cerebellum. Enlarged white boxed areas show tdTomato and parvalbumin expression in Purkinje cells in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ at P5. Scale bars: 500 μm (upper and middle panels), 10 μm (lower panel). (<bold>E</bold>) The DLK protein levels in cerebellar extracts from P10 mice of genotypes indicated were determined by western blot. (<bold>F</bold>) Quantification of the ratio of DLK relative to β-actin protein levels. (<bold>G</bold>) The LZK protein levels in cerebellar extracts from P21 mice of genotypes indicated were determined by immunoprecipitation and western blot. (<bold>H</bold>) Quantification of the ratio of LZK relative to β-actin protein levels. (<bold>I</bold>) Representative image of Calbindin staining of cerebellar section of Hipp11-DLK(iOE)/+ at P5 shows individual Calbindin<sup>+</sup> cells. (<bold>C, F, H</bold>) n = 3 animals per genotype; data shown are means ± SEM. Statistics: Student’s unpaired t-test; ns, no significant; *, p&lt;0.05; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Additional evidence of Purkinje cell degeneration phenotypes caused by elevated DLK expression.</title><p>(<bold>A</bold>) Representative image of P21 brains of genotypes indicated. Cerebellum is outlined to show smaller size with induced DLK expression in PV<sup>+</sup> neurons. Scale bar: 5 mm. (<bold>B</bold>) Representative images of hematoxylin and eosin (left panel), hematoxylin (enlarged red boxed areas, right panel) staining of cerebellar sections from P21 mice of genotypes indicated. Arrows point to the Purkinje cell bodies. Scale bars: 500 μm (left panel), 50 μm (right panel). (<bold>C</bold>) Representative images of cerebellar sections from P21 mice of genotypes indicated, immunostained for IBA1; and tdTomato reporter expression marks Purkinje cells. Arrows show close association between microglia and Purkinje cells. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bars: 100 μm. (<bold>D</bold>) Representative images of cerebellar sections from P21 mice of genotypes indicated, immunostained for GFAP. (<bold>E–F</bold>) IBA1 and GFAP staining intensity are quantified and normalized to Hipp11-DLK(iOE)/+ in cerebellum of P21 mice. n = 3 animals per genotype, three sections/animal. Data shown are means ± SEM. Statistics: Student’s unpaired t-test; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig2-figsupp2-v2.tif"/></fig></fig-group><p>To determine if targeted expression of DLK induced activation of the JNK signaling, we co-immunostained for phospho-c-Jun (p-c-Jun) and Calbindin on cerebellar tissue sections of P6 mice. While many p-c-Jun signals were likely from granule neurons as they did not overlap with Calbindin<sup>+</sup> Purkinje cells in both mutant and control mice, we observed that elevated DLK expression induced substantially increased p-c-Jun in Purkinje cells of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice, compared to littermate controls (<xref ref-type="fig" rid="fig3">Figure 3A–B</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). We also asked if the loss of Purkinje cells involved apoptosis using the TUNEL assay. During early postnatal cerebellar development, multiple types of cells undergo apoptosis, including those in the granular and the molecular layers of the cerebellar cortex (<xref ref-type="bibr" rid="bib9">Cheng et al., 2011</xref>). Indeed, in the control littermates, we observed many TUNEL signals at P5, which decreased over the following postnatal days (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A–B</xref>). In the <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice, the number of apoptotic cells at P5 was comparable to that in control, but continued to rise over the next 10 days, reaching peak levels around P15 (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A–B</xref>). Importantly, some TUNEL signals in P15 <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice co-localized with tdTomato-labeled Purkinje cells (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>). Furthermore, a significant portion of the Purkinje cells in the P15 <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice were positively stained for cleaved caspase-3 (<xref ref-type="fig" rid="fig3">Figure 3C–D</xref>), a marker for activating apoptosis (<xref ref-type="bibr" rid="bib14">Elmore, 2007</xref>). These results show that elevating DLK expression in Purkinje cells activates the JNK pathway and causes early-onset, rapid degeneration through apoptotic cell death.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Induced expression of DLK activates JNK signaling and apoptosis, and disrupts dendritic cytoskeleton of Purkinje cells.</title><p>(<bold>A</bold>) Representative images of co-immunostaining of p-c-Jun and Calbindin in Purkinje cells in P6 mice of genotypes indicated. Arrows point to p-c-Jun immunostaining signals in nuclei of Purkinje cells. Scale bar: 100 μm. (<bold>B</bold>) Quantification of percentage of p-c-Jun<sup>+</sup> signals per total Purkinje cells in P6 mice of Hipp11-DLK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+. (<bold>C</bold>) Representative images of cerebellar lobule III of P15 mice, co-immunostained for Calbindin and cleaved caspase-3, with arrows and enlarged blue boxes showing cleaved caspase-3<sup>+</sup> signals in the swollen dendrites of Purkinje cells of <italic>Pvalb<sup>Cre/+</sup>;</italic> Hipp11-DLK(iOE)/+ mice. Scale bars: 100 μm (left and middle panels), 50 μm (right panel). (<bold>D</bold>) Quantification of percentage of cleaved caspase-3<sup>+</sup> cells in total Purkinje cells in P15 mice of Hipp11-DLK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+, and none detected in Hipp11-DLK(iOE)/+. (<bold>E</bold>) Quantification of percentage of Purkinje cells with swelling dendrites in mice of Hipp11-DLK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ from P10 to P21, and none detected in Hipp11-DLK(iOE)/+. Hipp11-DLK(iOE)/+: n = 3 animals (P10, P15, P21), three sections/animal; <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-DLK(iOE)/+: n = 3 (P10, P21), n = 4 (P15) animals, three sections/animal. (<bold>F</bold>) Quantification of percentage of Purkinje cells containing cleaved caspase-3<sup>+</sup> in swelling dendrites in total Purkinje cells in P15 mice of Hipp11-DLK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+. (<bold>G</bold>) Representative images of Purkinje cells of P15 mice co-immunostained for MAP2 and Calbindin. Swelling dendrites in Purkinje cells of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice have little expression of MAP2; arrows point to dendrites with intensity difference between the two genotypes. Scale bar: 50 μm. (<bold>H</bold>) Representative images of Purkinje cells of P15 mice co-immunostained for NF-200 and Calbindin, showing that induced DLK expression reduces NF-200 staining in dendrites (arrows) and axons (arrowheads) of Purkinje cells. Scale bar: 50 μm. (<bold>B, D, F</bold>) n = 3 animals per genotype, three sections/animal. (<bold>B, D, E, F</bold>) Data shown are means ± SEM. Statistics: Student’s unpaired t-test; ****, p&lt;0.0001.</p><p> <supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Percentage of p-c-Jun<sup>+</sup> Purkinje cells in total Purkinje cells in P6 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig3-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Percentage of cleaved caspase-3<sup>+</sup> Purkinje cells in total Purkinje cells in P15 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig3-data2-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Percentage of Purkinje cells with swelling dendrites in mice of genotypes indicated from P10 to P21.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig3-data3-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Percentage of Purkinje cells containing cleaved caspase-3<sup>+</sup> in swelling dendrites in total Purkinje cells in P15 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig3-data4-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Additional evidence for p-c-Jun expression in cortex of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice.</title><p>Representative images of cortex of P15 mice of genotypes indicated, immunostained for p-c-Jun. Arrows point to the expression of p-c-Jun in tdTomato<sup>+</sup> cells of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+. Scale bar: 100 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Additional evidence for apoptosis induced by elevated DLK expression.</title><p>(<bold>A</bold>) Representative images of cerebellar lobules of Hipp11-DLK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice from P5 to P15, labeled with TUNEL fluorescence signal (fluorescein-12-dUTP). Scale bars: 100 μm. (<bold>B</bold>) Quantification of TUNEL<sup>+</sup> cells density in cerebellum. Hipp11-DLK(iOE)/+: n = 3 (P5), n = 4 (P10), n = 3 (P15), n = 3 (P21); <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+: n = 3 (P5), n = 3 (P10), n = 4 (P15), n = 3 (P21). Data shown are means ± SEM. Statistics: Student’s unpaired t-test; ns, no significant; **, p&lt;0.01; ***, p&lt;0.001. (<bold>C</bold>) Representative image showed the co-localization of TUNEL signal with tdT<sup>+</sup> Purkinje cells in P15 mice (arrows). ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bar: 50 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>DLK protein localization in Purkinje cells.</title><p>Representative images of cerebellar section of P10 mice immunostained for DLK; arrows show DLK distribution in Purkinje cells (arrows). ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bar: 100 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Additional images showing Purkinje cells that have dendrite swelling but are cleaved caspase-3<sup>-</sup> in <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-DLK(iOE)/+ mice at P15. Scale bar: 50 μm.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig3-figsupp4-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Elevated DLK expression disrupts dendritic cytoskeleton</title><p>DLK is known to be localized to neuronal processes (<xref ref-type="bibr" rid="bib59">Suenaga et al., 2006</xref>) and regulates microtubule stability (<xref ref-type="bibr" rid="bib57">Simard-Bisson et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Valakh et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Hirai et al., 2011</xref>). By immunostaining using anti-DLK antibodies on cerebellar sections of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice, we detected DLK expression in the somas, dendrites and axons of Purkinje cells (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). In these mice, a substantial portion of Purkinje cells, visualized by Calbindin, showed numerous varicosities along the dendrite arbors (<xref ref-type="fig" rid="fig3">Figure 3C,E</xref>, annotated dendrite swelling). Moreover, ~65% of Purkinje cells with dendrite swelling were positively stained for cleaved caspase-3 (<xref ref-type="fig" rid="fig3">Figure 3F</xref>; <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>). The percentage of Purkinje cells with dendrite swelling was highest around P15 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>), consistent with the time course of Purkinje cell death caused by increased DLK expression.</p><p>Dendrite swelling is associated with major disorganization of the cytoskeleton network (<xref ref-type="bibr" rid="bib11">Cupolillo et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Liu et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Hoskison et al., 2007</xref>). We next assessed how the microtubule cytoskeleton was altered by immunostaining for microtubule-associated protein 2 (MAP2), which is expressed in dendrites of Purkinje cells (<xref ref-type="bibr" rid="bib13">Dehmelt and Halpain, 2005</xref>). We found that MAP2 levels were significantly decreased in dendrites of Purkinje cells in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice, compared to the levels of Calbindin as well as to control mice at P15 (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). The neurofilament protein NF-200 is present in both dendrites and axons and implicated in axon growth and regeneration (<xref ref-type="bibr" rid="bib66">Wang et al., 2012</xref>). By immunostaining, we observed decreased levels of NF-200 in axons and dendrites of Purkinje cells in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). These data are consistent with the notion that DLK regulates the neuronal cytoskeleton, and suggest that the dendritic cytoskeleton in Purkinje cells may be prone for disruption upon aberrant activation of DLK, although we do not exclude the possibility that the dendrite cytoskeleton disruption could be a non-specific downstream effect.</p></sec><sec id="s2-4"><title>Elevating LZK expression in Purkinje cells causes late degeneration</title><p>In contrast to the early lethality of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ pups, the <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice survived to older adults (observed up to 8 months). The adult mice had low body weight, compared to control mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–B</xref>). Histological analysis showed all lobular structures were present in P120 <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). By Calbindin immunostaining we observed morphological abnormalities of Purkinje cells around P15, with severity and cell loss increasing from P21 to P120 (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>). The area of cerebellum and the molecular layer were also reduced significantly (<xref ref-type="fig" rid="fig4">Figure 4C–D</xref>). A previous study reported that <italic>Pvalb<sup>Cre</sup></italic> can induce higher levels of transgene expression in anterior zone than other zones of cerebellum (<xref ref-type="bibr" rid="bib3">Asrican et al., 2013</xref>). Consistently, we observed that the fluorescence intensities of tdTomato and LZK immunostaining were stronger in the anterior lobules than those in posterior cerebellum (<xref ref-type="fig" rid="fig4">Figure 4E</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D–E</xref>). Correlating with the expression levels of LZK, there were more Purkinje cells with severe abnormal cell morphology in the anterior cerebellum than the posterior (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Reduced MAP2 levels were also more noticeable in Purkinje cells located in the anterior than those in the posterior cerebellum (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Additionally, GFAP staining showed significantly increased astrocyte reactivity in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice from P21 (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A–B</xref>), particularly in areas surrounding Purkinje cells (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2C</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Induced expression of LZK using <italic>Pvalb<sup>Cre</sup></italic> causes progressive degeneration of Purkinje cells.</title><p>(<bold>A</bold>) Representative images of Calbindin staining of cerebellar sections of littermates from mating parents <italic>Pvalb<sup>Cre/+</sup></italic> to Hipp11-LZK(iOE)/+ at indicated postnatal days. Scale bars: 100 μm. (<bold>B</bold>) Quantification of total Purkinje cells in all cerebellar lobules. (<bold>C</bold>) Quantification of cerebellum area, perimeters measured by outlining the outer edge of cerebellum. (<bold>D</bold>) Quantification of the molecular layer thickness in cerebellar lobules V-VI. (<bold>E</bold>) Representative images of cerebellar sections of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice at P15, co-immunostained for MAP2 and Calbindin. The dotted lines in top panels mark the boundary of anterior zone (AZ; lobules I-V), central zone (CZ; lobules VI-VII), posterior zone (PZ; lobules VIII-XI) and nodular zone (NZ; lobule X) in cerebellum, note higher tdTomato intensity in anterior cerebellum (arrows and arrowheads). Images in the bottom two rows show enlarged views of the anterior and posterior cerebellum, with arrows pointing to dendrites of Purkinje cells. Scale bars: 500 μm (upper panel), 100 μm (middle and lower panels). (<bold>F</bold>) Representative images of Purkinje cells of P90 mice co-immunostained for Calbindin and p-c-Jun. Scale bar: 50 μm. (<bold>G</bold>) Representative images of Purkinje cells of P90 mice co-immunostained for Calbindin and cleaved caspase-3. Note that <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice have smaller cerebella, hence two rows of Purkinje cells are in view. Scale bar: 50 μm. (<bold>H</bold>) Quantification of the percentage of cleaved caspase-3<sup>+</sup> Purkinje cells in total Purkinje cells in Hipp11-LZK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-LZK(iOE)/+ mice from P10 to P120. Color representation for genotypes in C, D, H is the same as in B. (<bold>B–D, H</bold>) n = 3 animals per genotype, three sections/animal for each time point; data shown are means ± SEM. Statistics: Student’s unpaired t-test; ***, p&lt;0.001; ****, p&lt;0.0001.</p><p> <supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Total number of Purkinje cells in all cerebellar lobules of mice genotypes indicated from P15 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig4-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Mouse cerebellum area of genotypes indicated from P15 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig4-data2-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig4sdata3"><label>Figure 4—source data 3.</label><caption><title>Molecular layer thickness in cerebellar lobules V-VI of mice genotypes indicated from P15 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig4-data3-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig4sdata4"><label>Figure 4—source data 4.</label><caption><title>Percentage of cleaved caspase-3<sup>+</sup> Purkinje cells in total Purkinje cells in mice genotypes indicated from P10 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig4-data4-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Additional evidence for elevating LZK expression in PV<sup>+</sup> neurons causing animal growth and movement defects.</title><p>(<bold>A</bold>) Representative image of P120 mice of genotypes indicated. Scale bar: 2 cm. (<bold>B</bold>) Quantification of the body weight of mice of genotypes indicated from P15 to P120. Hipp11-LZK(iOE)/+: n = 4 (P15), n = 10 (P21), n = 10 (P30), n = 4 (P45), n = 11 (P60), n = 12 (P120); <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+: n = 5 (P15), n = 17 (P21), n = 14 (P30), n = 16 (P45), n = 20 (P60), n = 18 (P120). (<bold>C</bold>) Representative images of hematoxylin and eosin (left panel), hematoxylin (enlarged red boxed areas, right panel) staining of cerebellar sections from P120 mice of genotypes indicated. Arrows point to the Purkinje cell bodies. Scale bars: 500 μm (left panel), 50 μm (right panel). (<bold>D</bold>) Representative images of Purkinje cells of P21 mice immunostained for LZK. Enlarged blue boxed areas show transgenic LZK strongly expressed in dendrites and soma of Purkinje cells in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice. The red dotted lines mark the boundary of anterior zone (AZ; lobules I-V), central zone (CZ; lobules VI-VII), posterior zone (PZ; lobules VIII-XI), and nodular zone (NZ; lobule X) in cerebellum. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bars: 500 μm (whole sections), 100 μm (enlarged views). (<bold>E</bold>) Quantification of relative LZK protein levels in PC soma of anterior and posterior of cerebellum in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice. n = 3 animals per genotype, three sections/animal. (<bold>B, E</bold>) Data shown are means ± SEM. Statistics: Student’s unpaired t-test; ns, no significant; *, p&lt;0.05; ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Additional evidence for degeneration of Purkinje cells induced by elevated LZK expression.</title><p>(<bold>A</bold>) Representative images of GFAP staining of cerebellar astrocytes of the mice from P15 to P120. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bar: 100 μm. (<bold>B</bold>) GFAP staining intensity is quantified and normalized to Hipp11-LZK(iOE)/+ in cerebellum of the mice from P15 to P120. From P21, mice with induced LZK expression in PV<sup>+</sup> neurons have significantly higher GFAP levels in cerebellum than control Hipp11-LZK(iOE)/+ mice. Hipp11-LZK(iOE)/+: n = 3 (P15), n = 3 (P21), n = 9 (P30), n = 9 (P45), n = 12 (P60), n = 9 (P120) sections; <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-LZK(iOE)/+: n = 4 (P15), n = 3 (P21), n = 9 (P30), n = 9 (P45), n = 16 (P60), n = 9 (P120) sections. MFI: mean of fluorescence intensity. Data shown are means ± SEM. Statistics: Student’s unpaired t-test; ns, no significant; *, p&lt;0.05; ****, p&lt;0.0001. (<bold>C</bold>) Representative images of Purkinje cells and Bergmann glia in cerebellum of P45 mice, co-immunostained for Calbindin and GFAP. The death of Purkinje cells induced increased reactivity of their adjacent Bergmann glia (arrows). ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bar: 100 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig4-figsupp2-v2.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>Additional evidence of p-c-Jun expression in cortex of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice.</title><p>Representative images of cortex of P60 mice of genotypes indicated, immunostained for p-c-Jun. Arrows point to p-c-Jun expression in tdTomato<sup>+</sup> cells of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+. Scale bar: 100 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig4-figsupp3-v2.tif"/></fig></fig-group><p>We addressed whether Purkinje cell degeneration caused by LZK involved JNK activation and induction of apoptosis. While no detectable p-c-Jun was observed in Purkinje cells of P90 control mice, elevating LZK expression increased p-c-Jun in Purkinje cells (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Cleaved caspase-3 immunoreactivity co-localized with Purkinje cells in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice, but not in control mice (<xref ref-type="fig" rid="fig4">Figure 4G–H</xref>). Thus, elevating LZK expression also triggers JNK activation and caspase mediated apoptosis in Purkinje cells; however, these cells undergo a slow degeneration process. These data suggest differential regulation of the signaling network induced by elevated expression of DLK and LZK.</p></sec><sec id="s2-5"><title>Purkinje cell degeneration induced by LZK overexpression is attenuated by loss of CELF2, a regulator of <italic>Map2k7</italic> alternative splicing</title><p>Biochemical studies have shown that two MAP2K, MKK4 and MKK7 act downstream of DLK and LZK to activate JNK (<xref ref-type="bibr" rid="bib26">Hirai et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Le Pichon et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Huang et al., 2017</xref>; <xref ref-type="bibr" rid="bib32">Ikeda et al., 2001a</xref>; <xref ref-type="bibr" rid="bib7">Chen et al., 2016b</xref>; <xref ref-type="bibr" rid="bib33">Ikeda et al., 2001b</xref>; <xref ref-type="bibr" rid="bib27">Holland et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Merritt et al., 1999</xref>). However, in vivo evidence for how each MAP2K contributes to DLK- and LZK-induced signal transduction cascade in neurons is limited (<xref ref-type="bibr" rid="bib71">Yang et al., 2015</xref>; <xref ref-type="bibr" rid="bib36">Itoh et al., 2014</xref>). Recent studies of T-cell activation have reported that the activity of MKK7 is regulated through alternative splicing of its exon 2, which encodes a small peptide within the JNK docking site in MKK7 (<xref ref-type="bibr" rid="bib45">Martinez et al., 2015</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). During T-cell activation, the RNA splicing factor CELF2 promotes skipping of this exon, which favors the production of a short isoform of MKK7 that has high potency to activate JNK (<xref ref-type="bibr" rid="bib45">Martinez et al., 2015</xref>; <xref ref-type="bibr" rid="bib1">Ajith et al., 2016</xref>).</p><p>To test if this alternative splicing regulation of <italic>Map2k7,</italic> encoding mouse MKK7, has functional significance in neurons, we generated <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-DLK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice, along with <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup></italic> control mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>). By gross animal appearance and morphology of Purkinje cells, <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup></italic> mice were indistinguishable from the control mice <italic>Pvalb<sup>Cre/+</sup></italic> or <italic>Celf2<sup>fl/fl</sup></italic> (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D–H</xref>). In <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-DLK(iOE)/+ mice Purkinje cell degeneration phenotypes were similar to those in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D–F</xref>). Deletion of <italic>Celf2</italic> did not alter the expression levels of DLK (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1I</xref>), nor the induction of p-c-Jun by increased DLK expression (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1J–L</xref>). All pups of <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-DLK(iOE)/+ had smaller cerebellum (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1G</xref>), showed morbidity and low body weight (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1H</xref>), and died around P21. These data show that deletion of <italic>Celf2</italic> does not modify the phenotypes caused by increased DLK expression.</p><p>In contrast, <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice showed significantly improved composite behavioral phenotypes, compared to <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ from P30 to P120 (<xref ref-type="fig" rid="fig5">Figure 5A–E</xref>; <xref ref-type="video" rid="video2">Video 2</xref>), although the reduced body weight remained in <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). At the cellular level, deletion of <italic>Celf2</italic> dramatically reduced Purkinje cell degeneration induced by elevated LZK expression, with significant improvement in the dendrite morphology at P120 (<xref ref-type="fig" rid="fig5">Figure 5G–J</xref>). Deletion of <italic>Celf2</italic> also significantly inhibited astrogliosis and microgliosis in P120 <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice, compared to <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A–D</xref>). We detected a few microglia that appeared to contain dying Purkinje cells in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice but not in <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C</xref>; <xref ref-type="video" rid="video3">Video 3</xref>). Consistent with the suppression on Purkinje cell degeneration, deletion of <italic>Celf2</italic> also rescued the reduction of MAP2 and NF-200 in the molecular layer of cerebellum caused by elevated LZK expression (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3A–B</xref>). Additionally, immunostaining to parvalbumin and neurofilament enabled the visualization of the basket cells, which form specialized structures, called pinceau, onto the axon initial segment (AIS) of Purkinje cells (<xref ref-type="bibr" rid="bib49">Palay and Chan-Palay, 1974</xref>; <xref ref-type="bibr" rid="bib34">Ito, 1984</xref>). In <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice the pinceau were disorganized, which was suppressed by deletion of <italic>Celf2</italic> (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3B–C</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Deletion of the RNA splicing factor CELF2 using <italic>Pvalb<sup>Cre</sup></italic> rescues degeneration of Purkinje cells induced by elevated LZK expression.</title><p>(<bold>A–E</bold>) Quantification of movement phenotypes of mice of indicated genotypes from P30 to P120. <italic>Pvalb<sup>Cre/+</sup></italic>: n = 8 (P30), n = 17 (P45), n = 23 (P60), n = 19 (P75), n = 22 (P90), n = 12 (P105), n = 12 (P120); <italic>Pvalb<sup>Cre/+</sup></italic>;<italic>Celf2<sup>fl/fl</sup></italic>: n = 5 (P30), n = 8 (P45), n = 7 (P60), n = 6 (P75), n = 4 (P90), n = 4 (P105), n = 5 (P120); <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-LZK(iOE)/+: n = 21 (P30), n = 7 (P45), n = 20 (P60), n = 21 (P75), n = 26 (P90), n = 18 (P105), n = 19 (P120); <italic>Pvalb<sup>Cre/+</sup></italic>;<italic>Celf2<sup>fl/fl</sup></italic>;Hipp11-LZK(iOE)/+: n = 5 (P30), n = 8 (P45), n = 11 (P60), n = 11 (P75), n = 13 (P90), n = 8 (P105), n = 8 (P120). (<bold>F</bold>) Quantification of the body weight of mice of indicated genotypes from P30 to P120. <italic>Pvalb<sup>Cre/+</sup></italic>: n = 9 (P30), n = 9 (P45), n = 17 (P60), n = 14 (P75), n = 16 (P90), n = 10 (P105), n = 7 (P120); <italic>Pvalb<sup>Cre/+</sup></italic>;<italic>Celf2<sup>fl/fl</sup></italic>: n = 5 (P30), n = 5 (P45), n = 8 (P60), n = 6 (P75), n = 6 (P90), n = 5 (P105), n = 4 (P120); <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-LZK(iOE)/+: n = 14 (P30), n = 16 (P45), n = 20 (P60), n = 14 (P75), n = 20 (P90), n = 17 (P105), n = 18 (P120); <italic>Pvalb<sup>Cre/+</sup></italic>;<italic>Celf2<sup>fl/fl</sup></italic>;Hipp11-LZK(iOE)/+: n = 7 (P30), n = 7 (P45), n = 12 (P60), n = 12 (P75), n = 14 (P90), n = 10 (P105), n = 10 (P120). Color representation for genotypes in B-F is the same as in A. (<bold>G</bold>) Representative images of Calbindin staining of cerebellar sections from P120 mice of genotypes indicated. Scale bars: 100 μm. (<bold>H</bold>) Quantification of total Purkinje cells in all cerebellar lobules at P120. (<bold>I</bold>) Quantification of cerebellum area at P120. (<bold>J</bold>) Quantification of the molecular layer thickness of P120 mice in cerebellar lobules V-VI. (<bold>H–J</bold>) n = 3 animals per genotype, three sections/animal. (<bold>A–F, H–J</bold>) Data shown are means ± SEM; Statistics: one-way ANOVA; ns, no significant; *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p><p> <supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Score of ledge test of mice genotypes indicated from P30 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig5-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Score of kyphosis of mice genotypes indicated from P30 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig5-data2-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Score of gait of mice genotypes indicated from P30 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig5-data3-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig5sdata4"><label>Figure 5—source data 4.</label><caption><title>Score of hindlimb clasping of mice genotypes indicated from P30 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig5-data4-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig5sdata5"><label>Figure 5—source data 5.</label><caption><title>Composite phenotype score of mice genotypes indicated from P30 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig5-data5-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig5sdata6"><label>Figure 5—source data 6.</label><caption><title>Mouse body weight of genotypes indicated from P30 to P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig5-data6-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig5sdata7"><label>Figure 5—source data 7.</label><caption><title>Total Purkinje cells in all cerebellar lobules of mice of genotypes indicated at P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig5-data7-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig5sdata8"><label>Figure 5—source data 8.</label><caption><title>Mouse cerebellum area of genotypes indicated at P120.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig5-data8-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig5sdata9"><label>Figure 5—source data 9.</label><caption><title>Molecular layer thickness in cerebellar lobules V-VI of P120 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig5-data9-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>CELF2 is a regulator of <italic>Map2k7</italic> in Purkinje cells.</title><p>(<bold>A</bold>) Schematic of <italic>Map2k7</italic> locus on Chromosome 8, along with primers for mRNA detection of <italic>Map2k7</italic> isoforms. Scale bar: 1 kb. CELF2 promotes exclusion of exon 2 of <italic>Map2k7</italic>. The gel image shows the RT-PCR analysis of the <italic>Map2k7</italic> long isoform (<italic>Map2k7-L</italic>) and short isoform (<italic>Map2k7-S</italic>) as well as <italic>β-actin</italic> mRNA levels in cerebellum of <italic>Pvalb<sup>Cre/+</sup></italic> mouse using primers YJ12516-12519. (<bold>B</bold>) qRT-PCR analyses show the mRNA ratio of <italic>Map2k7-S</italic>/<italic>Map2k7-L</italic> in cerebellum from P21 mice of genotypes indicated. RNA samples are collected from n = 3 animals/genotype. For qRT-PCR, n = 5 replicates/sample. (<bold>C</bold>) The <italic>Celf2<sup>fl/fl</sup></italic> mice have two loxP sites flanking exon 3, and Cre-mediated excision results in an early stop codon within exon 4, hence a null allele. The homozygotes or heterozygotes of <italic>Celf2<sup>fl</sup></italic> were identified by PCR using primers YJ12527 and YJ12528. (<bold>D</bold>) Representative images of Calbindin staining of cerebellar sections from P21 mice of genotypes indicated. Scale bars: 500 μm. (<bold>E</bold>) Quantification of total number of PCs in all cerebellar lobules. (<bold>F</bold>) Quantification of the molecular layer thickness in cerebellar lobules V-VI. (<bold>G</bold>) Quantification of the cerebellum area of P21 mice. (<bold>H</bold>) Quantification of the body weight of P21 mice of genotypes indicated. Hipp11-DLK(iOE)/+: n = 9; <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup></italic>: n = 9; <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+: n = 8; <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-DLK(iOE)/+: n = 7. (<bold>I</bold>) The DLK protein levels in cerebellum from P10 mice of genotypes indicated were determined by western blot. n = 3 per group. (<bold>J</bold>) Representative images of Purkinje cells of P15 mice of genotypes indicated, co-immunostained for Calbindin and p-c-Jun. <italic>Celf2</italic> deletion did not reduce the phosphorylation level of c-Jun induced by DLK overexpression in PV<sup>+</sup> neurons (arrows), nor rescued the dendrite swelling caused by DLK overexpression in PV<sup>+</sup> neurons (arrowheads). ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bar: 100 μm. (<bold>K</bold>) Quantification of the p-c-Jun levels in Purkinje cells of P15 mice. MFI: mean of fluorescence intensity. (<bold>L</bold>) p-c-Jun areas are quantified and normalized to <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ in Purkinje cells of P15 mice. (<bold>E–G, K–L</bold>) n = 3 animals per genotype, three sections/animal. (<bold>B, E–H, K–L</bold>) Data shown are means ± SEM; Statistics: one-way ANOVA; ns, no significant; *, p&lt;0.05; **, p&lt;0.01; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>CELF2 deletion reduces astrogliosis and microgliosis associated with LZK in PV<sup>+</sup> neurons.</title><p>(<bold>A</bold>) Representative images of GFAP staining of cerebellar astrocytes from P120 mice of genotypes indicated. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bars: 100 μm. (<bold>B</bold>) GFAP staining intensity is quantified and normalized to <italic>Pvalb<sup>Cre/+</sup></italic> in cerebellum of P120 mice. <italic>Pvalb<sup>Cre/+</sup></italic>: n = 6 animals, three sections/animal; <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>, Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+: n = 3 animals per genotype, three sections/animal. MFI: mean of fluorescence intensity. (<bold>C</bold>) Representative images of cerebellar sections from P120 mice of genotypes indicated, co-immunostained for IBA1 and Calbindin. Enlarged white boxed areas show Calbindin-stained materials are within IBA1<sup>+</sup> microglia. The views are from single-focal plane and a 3D reconstructed image, respectively. Scale bar: 100 μm (upper three panels), 10 μm (lower panel). ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. (<bold>D</bold>) IBA1 staining intensity is quantified and normalized to <italic>Pvalb<sup>Cre/+</sup></italic> in cerebellum of P120 mice. n = 3 animals per genotype, three sections/animal. MFI: mean of fluorescence intensity. (<bold>B, D</bold>) Data shown are means ± SEM; Statistics: one-way ANOVA; ns, no significant; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>CELF2 deletion rescues reduced expression of MAP2 and NF-200 and pinceau disorganization induced by elevated LZK expression.</title><p>(<bold>A</bold>) Representative images of cerebellar sections from P120 mice of genotypes indicated, co-immunostained for Calbindin and MAP2. Arrows point to MAP2 staining in dendrites of Purkinje cells. (<bold>B</bold>) Representative images of cerebellar sections from P120 mice of genotypes indicated, co-immunostained for NF-200 and Calbindin. LZK overexpression in PV<sup>+</sup> neurons changes the organization of basket cell pinceaux (arrows) at the initial segment of axons of Purkinje cells, which is suppressed by <italic>Celf2</italic> deletion. (<bold>A–B</bold>) ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bar: 50 μm. (<bold>C</bold>) Representative images of parvalbumin staining of cerebellar sections from P120 mice of genotypes indicated. Enlarged white boxed areas in lower panel show suppression of pinceaux disorganization by <italic>Celf2</italic> deletion. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bars: 500 μm (upper panel), 100 μm (lower panel).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig5-figsupp3-v2.tif"/></fig></fig-group><media id="video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-63509-video2.mp4"><label>Video 2.</label><caption><title>Locomotor deficits in P120 <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-LZK(iOE)/+ mice.</title><p>A representative P120 old <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mouse exhibited severe limp while walking and tremors.</p></caption></media><media id="video3" mime-subtype="mp4" mimetype="video" xlink:href="elife-63509-video3.mp4"><label>Video 3.</label><caption><title>Calbindin<sup>+</sup> staining materials are present inside of IBA1<sup>+</sup> cells in P120 <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-LZK(iOE)/+ mice.</title><p>A video showing the 3D reconstruction image of Calbindin<sup>+</sup> staining materials in the microglia or macrophage cell body.</p></caption></media><p>To address whether CELF2 was involved in LZK signaling in Purkinje cells, we examined exon 2 splicing of <italic>Map2k7</italic>. By qRT-PCR analysis, we detected that <italic>Celf2</italic> deletion reduced mRNA ratio of the short isoform (<italic>Map2k7-S</italic>) to the long isoform (<italic>Map2k7-L</italic>) by ~20% in cerebellum of <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice, compared to <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). The overall expression levels of LZK in cerebellum were not altered by <italic>Celf2</italic> deletion (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A–B</xref>). We then immunostained for p-c-Jun in cerebellum of P120 mice. LZK overexpression induced p-c-Jun in most of Purkinje cells, and <italic>Celf2</italic> deletion significantly attenuated the intensity of p-c-Jun in Purkinje cells of <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). The total number of dying cells, marked by TUNEL signals, in cerebellum of <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice was significantly reduced, compared to that in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D–E</xref>). A few TUNEL signals (approximately one cell/section) were co-localized with tdTomato-labeled Purkinje cells in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice, but not in <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1F</xref>). Cleaved caspase-3 signals were rarely detected in Purkinje cells of <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice, compared to <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice (<xref ref-type="fig" rid="fig6">Figure 6C–D</xref>). We further assessed expression levels of Bcl-xL (B-cell lymphoma-extra Large), which as a full-length protein prevents caspase activation, but the cleaved protein product promotes apoptosis (<xref ref-type="bibr" rid="bib19">Gross et al., 1999</xref>). Western blot analysis of cerebellar protein extracts from P21 mice when minimal Purkinje cell degeneration was detected in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ showed increased pro-apoptotic cleavage products of Bcl-xL, compared to control samples (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A,C</xref>). These data support a conclusion that <italic>Celf2</italic> deletion attenuates LZK-induced JNK signaling, and provide in vivo evidence that MKK7 is a functional mediator of LZK signaling in Purkinje cells.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Deletion of CELF2 in <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-LZK(iOE)/+ mice reduces levels of p-c-Jun and apoptosis in Purkinje cells.</title><p>(<bold>A</bold>) Representative images of Purkinje cells, co-immunostained for p-c-Jun and Calbindin, in P120 mice of genotypes indicated. Arrows point to p-c-Jun immunostaining signals in Purkinje cells. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bar: 100 μm. (<bold>B</bold>) Quantification of the p-c-Jun levels in Purkinje cells of P120 mice. MFI: mean of fluorescence intensity. (<bold>C</bold>) Representative images of Purkinje cells, co-immunostained for cleaved caspase-3 and Calbindin, in P120 mice of genotypes indicated, with enlarged boxes showing cleaved caspase-3<sup>+</sup> signal in Calbindin-labeled Purkinje cells. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bars: 100 μm. (<bold>D</bold>) Quantification of the percentage of cleaved caspase-3<sup>+</sup> Purkinje cells in total number of Purkinje cells of P120 mice of genotypes indicated. (<bold>B, D</bold>) n = 3 animals per genotype, three sections/animal; data shown are means ± SEM. Statistics: one-way ANOVA; ns, no significant; ****, p&lt;0.0001.</p><p> <supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>p-c-Jun levels in Purkinje cells of P120 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig6-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Percentage of cleaved caspase-3<sup>+</sup> Purkinje cells in total number of Purkinje cells of P120 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig6-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Additional evidence of apoptosis in Purkinje cell degeneration caused by elevated LZK expression.</title><p>(<bold>A</bold>) Western blot showing LZK and Bcl-xL protein levels in cerebellar extracts from P21 mice of genotypes indicated. The LZK proteins were first immunoprecipitated and then analyzed by western blot. (<bold>B</bold>) LZK protein levels are quantified and normalized to <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+. n = 3 animals per genotype. Data shown are means ± SEM. Statistics: Student’s unpaired t-test; ns, no significant. (<bold>C</bold>) Quantification of the ratio of cleaved Bcl-xL relative to β-actin protein levels. n = 3 animals per genotype. Data shown are means ± SEM. Statistics: one-way ANOVA; ns, no significant; ***, p&lt;0.001. (<bold>D</bold>) Representative images of TUNEL fluorescence signal (fluorescein-12-dUTP) in cerebellar lobules of P120 mice of genotypes indicated. Scale bars: 100 μm. (<bold>E</bold>) Quantification of the percentage of TUNEL<sup>+</sup> Purkinje cells in total Purkinje cells (tdTomato<sup>+</sup>) in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice at P120. n = 3 animals per genotype, three sections/animal. Data shown are means ± SEM. Statistics: Student’s unpaired t-test; ****, p&lt;0.0001. (<bold>F</bold>) Representative images of cerebellar sections of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice labeled with TUNEL fluorescence signal and reporter tdTomato. The TUNEL signal was co-localized with Purkinje cells in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice (arrow), but not in <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bars: 100 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig6-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-6"><title>DLK and LZK can induce Purkinje cell degeneration independent of each other</title><p>DLK and LZK have a nearly identical kinase domain, and are reported to bind and be co-immunoprecipitated from mouse brain (<xref ref-type="bibr" rid="bib50">Pozniak et al., 2013</xref>). Recent studies have also shown that in injured RGCs or DRGs the two kinases have redundant or synergistic interactions (<xref ref-type="bibr" rid="bib69">Welsbie et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Summers et al., 2020</xref>). We next addressed whether the Purkinje cell degeneration caused by elevating DLK or LZK activity depends on the presence of one another by analyzing <italic>Pvalb<sup>Cre/+</sup>;Map3k13<sup>KO/KO</sup>;</italic>Hipp11-DLK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice.</p><p>In <italic>Pvalb<sup>Cre/+</sup>;Map3k13<sup>KO/KO</sup>;</italic>Hipp11-DLK(iOE)/+ mice, Purkinje cell degeneration and astrogliosis proceeded temporally and spatially similar to that of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ (<xref ref-type="fig" rid="fig7">Figure 7A–E</xref>). The elevated p-c-Jun levels in Purkinje cells of <italic>Pvalb<sup>Cre/+</sup></italic>;Hipp11-DLK(iOE)/+ mice at P10 were not affected by deleting <italic>Mapk3k13,</italic> encoding LZK (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A–B</xref>). All pups of <italic>Pvalb<sup>Cre/+</sup>;Map3k13<sup>KO/KO</sup></italic>;Hipp11-DLK(iOE)/+ died by P21, with similar morbidity as <italic>Pvalb<sup>Cre/+</sup></italic>; Hipp11-DLK(iOE)/+. Conversely, the <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ mice resembled <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice in the slow degeneration of Purkinje cells. Both <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice had low body weight (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>) and small cerebellum area at P60 (<xref ref-type="fig" rid="fig7">Figure 7I</xref>), compared to the control mice. By immunostaining with Calbindin and GFAP antibodies, we observed that removing <italic>Map3k12,</italic> encoding DLK, did not alter Purkinje cell degeneration or astrogliosis caused by LZK expression (<xref ref-type="fig" rid="fig7">Figure 7F,H,J</xref>). The levels of p-c-Jun induced by LZK expression in Purkinje cells remained comparable, with or without endogenous DLK (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1D–E</xref>). These data show that targeted activation of each kinase induces Purkinje cell degeneration largely independent of each other.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>DLK and LZK can induce Purkinje cell degeneration independent of each other.</title><p>(<bold>A</bold>) Representative images of immunostainning for Calbindin (upper panels) and GFAP (lower panels) of cerebellar sections of P21 mice of genotypes indicated. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bars: 100 μm. (<bold>B</bold>) Quantification of total number of Purkinje cells in all cerebellar lobules at P21. (<bold>C</bold>) Quantification of the molecular layer thickness in cerebellar lobules V-VI of P21 mice. (<bold>D</bold>) Quantification of the cerebellum area of P21 mice. (<bold>E</bold>) GFAP staining intensity is quantified and normalized to Hipp11-DLK (iOE)/+ in cerebellum of P21 mice. MFI: mean of fluorescence intensity. (<bold>F</bold>) Representative images of immunostaining for Calbindin (upper panels) and GFAP (lower panels) of cerebellar sections of P60 mice of genotypes indicated. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bars: 100 μm. (<bold>G</bold>) Quantification of total number of Purkinje cells in all cerebellar lobules of P60 mice. (<bold>H</bold>) Quantification of the molecular layer thickness in cerebellar lobules V-VI of P60 mice. <italic>Map3k12<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+: n = 5 animals, three sections/animal; <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup></italic> and <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+: n = 3 animals, three sections/animal. (<bold>I</bold>) Quantification of the cerebellum area of P60 mice. (<bold>J</bold>) GFAP staining intensity is quantified and normalized to <italic>Map3k12<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+ in cerebellum of P60 mice. MFI: mean of fluorescence intensity. <italic>Map3k12<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+: n = 5 animals, three sections/animal; <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup></italic>, <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;Map3k12<sup>fl/fl</sup>;</italic>Hipp11-LZK(iOE)/+: n = 3 animals, three sections/animal. (<bold>B–E, G, I</bold>) n = 3 animals per genotype, three sections/animal. (<bold>B–E, G–J</bold>) Data shown are means ± SEM; Statistics: one-way ANOVA; ns, no significant; ****, p&lt;0.0001.</p><p> <supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Total number of Purkinje cells in all cerebellar lobules of P21 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig7-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Molecular layer thickness in cerebellar lobules V-VI of P21 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig7-data2-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig7sdata3"><label>Figure 7—source data 3.</label><caption><title>Cerebellum area of P21 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig7-data3-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig7sdata4"><label>Figure 7—source data 4.</label><caption><title>Normalized GFAP levels in cerebellum of P21 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig7-data4-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig7sdata5"><label>Figure 7—source data 5.</label><caption><title>Total number of Purkinje cells in all cerebellar lobules of P60 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig7-data5-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig7sdata6"><label>Figure 7—source data 6.</label><caption><title>Molecular layer thickness in cerebellar lobules V-VI of P60 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig7-data6-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig7sdata7"><label>Figure 7—source data 7.</label><caption><title>Cerebellum area of P60 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig7-data7-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig7sdata8"><label>Figure 7—source data 8.</label><caption><title>Normalized GFAP levels in cerebellum of P60 mice of genotypes indicated.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63509-fig7-data8-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Levels of p-c-Jun induced by elevated expression of DLK or LZK is not affected by loss of LZK or DLK, respectively.</title><p>(<bold>A</bold>) LZK deletion did not attenuate the phosphorylation of c-Jun induced by DLK overexpression in PV<sup>+</sup> neurons. Shown are representative images of cerebellar sections of P10 mice, co-immunostained for p-c-Jun and Calbindin. EGL: External Granule Layer; ML: Molecular Layer; PCL: Purkinje Cell Layer; IGL: Internal Granule Layer. Scale bar: 100 μm. (<bold>B</bold>) Quantification of the p-c-Jun levels in Purkinje cells of P10 mice of genotype indicated. MFI: mean of fluorescence intensity. (<bold>C</bold>) Quantification of the body weight of P60 mice of genotypes indicated. n = 10 animals per genotype. (<bold>D</bold>) DLK deletion did not attenuate the phosphorylation of c-Jun induced by LZK overexpression in PV<sup>+</sup> neurons. Shown are representative images of cerebellar lobules of P60 mice, co-immunostained for Calbindin and p-c-Jun. ML: Molecular Layer; PCL: Purkinje Cell Layer; GCL: Granule Cell Layer. Scale bar: 100 μm. (<bold>E</bold>) Quantification of the p-c-Jun levels in Purkinje cells of P60 mice. MFI: mean of fluorescence intensity. (<bold>B, E</bold>) n = 3 animals per genotype, three sections/animal. (<bold>B, C, E</bold>) Data shown are means ± SEM; Statistics: one-way ANOVA; ns, no significant; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Summary of Purkinje cell death observed in the mice with elevated expression of two MAP3Ks.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63509-fig7-figsupp2-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we have used cerebellar Purkinje cells to gain a systematic understanding of the function of two closely related kinases, DLK (MAP3K12) and LZK (MAP3K13), that have emerged as key players in neural protection under injury and disease (<xref ref-type="bibr" rid="bib2">Asghari Adib et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Jin and Zheng, 2019</xref>; <xref ref-type="bibr" rid="bib15">Farley and Watkins, 2018</xref>). We employed both conditional KO and transgenic Cre-inducible expression mice to manipulate levels of DLK and LZK expression. We find that while deleting one or both kinases in Purkinje cells postnatally did not affect their development, elevating expression of DLK or LZK, which leads to their activation, causes Purkinje cell degeneration. Our Cre-inducible DLK and LZK transgenes have the same design and are inserted in the same genomic locus to avoid position effect on transgene expression. Despite the similarly targeted transgenes, we found that DLK elevation triggers rapid degeneration of Purkinje cells, while LZK elevation causes slow degeneration (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>). Each kinase activates JNK signaling, measured by increased phosphorylated c-Jun, and induces apoptosis. Each kinase can induce neuron degeneration in the absence of the other. Importantly, we show that deletion of mRNA splicing factor CELF2 strongly attenuates Purkinje cell degeneration caused by LZK, but not DLK, providing further evidence for a signaling pathway-specific effect for each kinase rather than a generic, secondary effect of overexpressing any kinase. These data support the utility of our transgenic mice for dissecting cell-type specific roles of these kinases and their signaling pathways.</p><p>Our findings that DLK and LZK are dispensable for postnatal development of Purkinje cells are in line with the report that adult knockout of DLK exhibit nearly normal function (<xref ref-type="bibr" rid="bib40">Le Pichon et al., 2017</xref>; <xref ref-type="bibr" rid="bib50">Pozniak et al., 2013</xref>), but are in contrast to the previous studies that in DLK constitutive knockout mice the developing spinal cord motor neurons and periphery sensory neurons show increased survival (<xref ref-type="bibr" rid="bib35">Itoh et al., 2011</xref>; <xref ref-type="bibr" rid="bib54">Sengupta Ghosh et al., 2011</xref>). These studies support the general notion that these two kinases exert cell-type, stage- and context-dependent effects. Additionally, we observed body weight loss, motor deficits and early mortality associated with <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ pups. Parvalbumin-Cre is expressed widely throughout the nervous system, including many interneurons in the brain and sensory neurons in periphery nervous system (<xref ref-type="bibr" rid="bib22">Hippenmeyer et al., 2005</xref>). Purkinje cells are not essential for animal viability. While our data do not address the cellular and/or circuit basis of these gross phenotypes, we infer that the grossly abnormality and lethality of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ pups are unlikely the consequence of Purkinje cell death alone. The underlying basis would be of interest in future studies.</p><p>DLK and LZK share a kinase domain that is ~90% identical and can activate the JNK signaling pathway through two MAPKK, MKK4, or MKK7 (<xref ref-type="bibr" rid="bib26">Hirai et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Le Pichon et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Huang et al., 2017</xref>; <xref ref-type="bibr" rid="bib32">Ikeda et al., 2001a</xref>; <xref ref-type="bibr" rid="bib7">Chen et al., 2016b</xref>; <xref ref-type="bibr" rid="bib33">Ikeda et al., 2001b</xref>; <xref ref-type="bibr" rid="bib27">Holland et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Merritt et al., 1999</xref>). While some in vivo studies have supported that MKK4 is a major mediator for DLK (<xref ref-type="bibr" rid="bib71">Yang et al., 2015</xref>; <xref ref-type="bibr" rid="bib36">Itoh et al., 2014</xref>), currently little is known about which MAPKK mediates LZK signaling. Our data show that elevating DLK expression in Purkinje cells leads to robust JNK signaling, compared to LZK. The observation that deletion of CELF2 did not affect any phenotypes caused by elevated DLK expression could be due to a combination of the strong JNK activation and the rapid time course of cell death. In contrast, deletion of CELF2 significantly reduced the activation of c-Jun and almost completely rescued the Purkinje cell degeneration caused by elevated LZK expression. These data are consistent with the role of CELF2 in regulating alternative splicing of <italic>Map2k7</italic> (encoding MKK7) (<xref ref-type="bibr" rid="bib45">Martinez et al., 2015</xref>), and support that MKK7 is a functional downstream kinase for LZK in vivo. The observation that CELF2 deletion led to a more prominent reduction of cleaved caspase-3 than p-c-Jun levels implies that apoptotic pathway downstream of LZK is more sensitive to MKK7 activity, while other unidentified MAP2K may also act downstream of LZK.</p><p>Numerous studies have revealed roles of DLK in axon growth, regeneration, and/or degeneration (<xref ref-type="bibr" rid="bib63">Tedeschi and Bradke, 2013</xref>; <xref ref-type="bibr" rid="bib37">Jin and Zheng, 2019</xref>; <xref ref-type="bibr" rid="bib2">Asghari Adib et al., 2018</xref>). DLK is also known to regulate microtubule stability (<xref ref-type="bibr" rid="bib57">Simard-Bisson et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Valakh et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Hirai et al., 2011</xref>), and several microtubule-associated proteins such as SCG10, DCX, and MAP2 are JNK substrates (<xref ref-type="bibr" rid="bib5">Chang et al., 2003</xref>; <xref ref-type="bibr" rid="bib16">Gdalyahu et al., 2004</xref>; <xref ref-type="bibr" rid="bib61">Tararuk et al., 2006</xref>; <xref ref-type="bibr" rid="bib4">Björkblom et al., 2005</xref>). Our analyses on Purkinje cells are consistent with the known roles of DLK and JNK regulation of microtubule associated proteins. Comparatively, not much is known about the roles of LZK in neurons. We show that deleting LZK does not disrupt Purkinje cell morphology, but increasing LZK expression caused reduced neurofilament levels in the molecular layer of cerebellum and disorganization of the pinceau at the axon initial segment of Purkinje cell. LZK expression also significantly decreased MAP2 levels in dendrites of Purkinje cells, and CELF2 deletion restored MAP2 levels only in <italic>Pvalb<sup>Cre/+</sup>;Celf2<sup>fl/fl</sup></italic>;Hipp11-LZK(iOE)/+ mice. These data begin to uncover the cellular effects of LZK signaling in neurons.</p><p>There is mounting evidence in the literature on the upregulation of the DLK and LZK signaling pathway in CNS injury and neurodegeneration (<xref ref-type="bibr" rid="bib67">Watkins et al., 2013</xref>; <xref ref-type="bibr" rid="bib68">Welsbie et al., 2013</xref>; <xref ref-type="bibr" rid="bib38">Joy et al., 2019</xref>; <xref ref-type="bibr" rid="bib40">Le Pichon et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Huang et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Chen et al., 2018</xref>), indicating that altered signaling of this pathway may be a prevalent feature in CNS injury and diseases. Along this line, genetic studies of DLK in both invertebrate and vertebrate species have revealed prominent developmental defects with DLK activation rather than inactivation (<xref ref-type="bibr" rid="bib41">Lewcock et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Nakata et al., 2005</xref>; <xref ref-type="bibr" rid="bib10">Collins et al., 2006</xref>; <xref ref-type="bibr" rid="bib18">Grill et al., 2016</xref>). Our findings show that DLK-induced signal transduction cascade triggers a strong or rapid cellular response, which may be more suited under conditions of traumatic injury or insults, while LZK induces modest activation of JNK and apoptosis, which may manifest in chronic neurodegenerative diseases. Besides the kinase domain and leucine-zipper domain, both MAP3Ks have large uncharacterized C-terminus, which may play significant roles in regulating the signaling strength of each protein. As DLK and LZK activity exhibits high cell-type and context-dependent specificity, our transgenic mice offer valuable gain of function models to study their signaling pathways with the ease for temporal and spatial manipulation. The knowledge learned will advance our understanding of how diverse neuronal types respond to insults to the nervous system.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>B6.129P2-<italic>Pvalb<sup>tm1(cre)Arbr</sup></italic>/J <break/>(<italic>Pvalb<sup>Cre</sup></italic>)</td><td>Jackson Laboratory</td><td>Stock #: 017320 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI_3590684">MGI_3590684</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>C57BL/6J</td><td>Jackson Laboratory</td><td>Stock #: 000664 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI_3028467">MGI_3028467</ext-link></td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>Inducible DLK overexpression: <break/>Hipp11-DLK(iOE)</td><td>This paper</td><td/><td>housed in UCSD vivarium</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>Inducible LZK overexpression: Hipp11-LZK(iOE)</td><td>This paper</td><td/><td>housed in UCSD vivarium</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>Conditional DLK knockout (<italic>Map3k12<sup>fl</sup></italic>)</td><td><xref ref-type="bibr" rid="bib7">Chen et al., 2016b</xref></td><td/><td>housed in UCSD vivarium</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>Conditional LZK knockout (<italic>Map3k13<sup>fl</sup></italic>)</td><td><xref ref-type="bibr" rid="bib7">Chen et al., 2016b</xref></td><td/><td>housed in UCSD vivarium</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>Conditional <italic>Celf2</italic> knockout (<italic>Celf2<sup>fl</sup></italic>)</td><td><xref ref-type="bibr" rid="bib6">Chen et al., 2016a</xref></td><td/><td>housed in UCSD vivarium</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td>CRISPR LZK knockout (<italic>Map3k13<sup>KO</sup></italic>)</td><td>This paper</td><td/><td>housed in UCSD vivarium</td></tr><tr><td>Antibody</td><td>Anti-MAP3K12 (rabbit polyclonal)</td><td>Sigma-Aldrich</td><td>Cat. #: SAB2700169 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2714162">AB_2714162</ext-link></td><td>WB (1:2000), <break/>IF (1:250)</td></tr><tr><td>Antibody</td><td>Anti-MAP3K13 <break/>(rabbit polyclonal)</td><td>Sigma-Aldrich</td><td>Cat. #: HPA016497 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10670027">AB_10670027</ext-link></td><td>WB (1:300), <break/>IF (1:200), <break/>IP (2 μg per sample)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Actin (Clone C4) (mouse monoclonal)</td><td valign="top">MP Biomedicals</td><td valign="top">Cat. #: 08691001 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2335127">AB_2335127</ext-link></td><td valign="top">WB (1:10,000)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Bcl-xL (54H6) (rabbit monoclonal)</td><td valign="top">Cell signaling</td><td valign="top">Cat. #: 2764 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2228008">AB_2228008</ext-link></td><td valign="top">WB (1:2000)</td></tr><tr><td>Antibody</td><td valign="top">Anti-FLAG (rabbit polyclonal)</td><td valign="top">Millipore</td><td valign="top">Cat. #: F7425 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_439687">AB_439687</ext-link></td><td valign="top">WB (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Sheep anti-mouse IgG (sheep polyclonal, HRP conjugated)</td><td valign="top">GE healthcare</td><td valign="top">Cat. #: NA931 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_772210">AB_772210</ext-link></td><td valign="top">WB (1:5000)</td></tr><tr><td>Antibody</td><td valign="top">Donkey anti-rabbit IgG (donkey polyclonal, HRP conjugated)</td><td valign="top">GE healthcare</td><td valign="top">Cat. #: NA934 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_772206">AB_772206</ext-link></td><td valign="top">WB (1:5000)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Iba1 (rabbit polyclonal)</td><td valign="top">Wako</td><td valign="top">Cat. #: 019–19741 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_839504">AB_839504</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Neurofilament 200 (Phos. and Non-Phos.) (mouse monoclonal)</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat. #: N0142 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477257">AB_477257</ext-link></td><td valign="top">IF (1:200)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Phospho-c-Jun (Ser73) (D47G9) XP (rabbit monoclonal)</td><td valign="top">Cell signaling</td><td valign="top">Cat. #: 3270 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2129575">AB_2129575</ext-link></td><td valign="top">IF (1:200)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Cleaved Caspase-3 (Asp175) (rabbit polyclonal)</td><td valign="top">Cell signaling</td><td valign="top">Cat. #: 9661 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2341188">AB_2341188</ext-link></td><td valign="top">IF (1:200)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Calbindin (D1I4Q) XP (rabbit monoclonal)</td><td valign="top">Cell signaling</td><td valign="top">Cat. #: 13176 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687400">AB_2687400</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Calbindin D-28k (mouse monoclonal)</td><td valign="top">Swant</td><td valign="top">Cat. #: 300 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10000347">AB_10000347</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Anti-GFAP (2.2B10) (rat monoclonal)</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Cat. #: 13–0300 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2532994">AB_2532994</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Anti-MAP2 (chicken polyclonal)</td><td valign="top">Abcam</td><td valign="top">Cat. #: ab5392 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2138153">AB_2138153</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Anti-Parvalbumin (guinea pig polyclonal)</td><td valign="top">Synaptic systems</td><td valign="top">Cat. #: 195004 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2156476">AB_2156476</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Anti-tdTomato (goat polyclonal)</td><td valign="top">SICGEN</td><td valign="top">Cat. #: AB8181-200 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2722750">AB_2722750</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Goat anti-mouse IgG (H+L) (goat polyclonal, Alexa Fluor 647 conjugated)</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: A21236 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535805">AB_2535805</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Goat anti-guinea Pig IgG (H+L) (goat polyclonal, Alexa Fluor 488 conjugated)</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: A11073 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534117">AB_2534117</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Goat anti-rabbit IgG (H+L) <break/>(goat polyclonal, Alexa Fluor 488 conjugated)</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: A11008 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_143165">AB_143165</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Goat anti-rabbit IgG (H+L) (goat polyclonal, Alexa Fluor 647 conjugated)</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: A21245 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535813">AB_2535813</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Goat anti-mouse IgG (H+L) (goat polyclonal, Alexa Fluor 488 conjugated)</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: A11001 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534069">AB_2534069</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Goat anti-rat IgG (H+L) (goat polyclonal, Alexa Fluor 488 conjugated)</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: A11006 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_141373">AB_141373</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Antibody</td><td valign="top">Goat anti-chicken IgG (H+L) (goat polyclonal, Alexa Fluor 647 conjugated)</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: A21449 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1500594">AB_1500594</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td>Recombinant DNA reagent</td><td>pBT378-LSL-3X Flag-DLK-T2A-tdTomato (plasmid)</td><td>This paper</td><td/><td>Construct Hipp11-DLK(iOE) mice</td></tr><tr><td>Recombinant DNA reagent</td><td>pBT378-LSL-1X Flag-LZK-T2A-tdTomato (plasmid)</td><td>This paper</td><td/><td>Construct Hipp11-LZK(iOE) mice</td></tr><tr><td>Sequence-based reagent</td><td valign="top">sgRNA2-Fw</td><td>This paper</td><td/><td valign="top">CACCGTGGCACTACAGGTCACATAC</td></tr><tr><td>Sequence-based reagent</td><td valign="top">sgRNA2-Re</td><td valign="top">This paper</td><td/><td valign="top">AAACGTATGTGACCTGTAGTGCCAC</td></tr><tr><td>Sequence-based reagent</td><td valign="top">sgRNA5-Fw</td><td valign="top">This paper</td><td/><td valign="top">CACCGGACCTCGTACAGCTGTCCGT</td></tr><tr><td>Sequence-based reagent</td><td valign="top">sgRNA5-Re</td><td>This paper</td><td/><td valign="top">AAACACGGACAGCTGTACGAGGTCC</td></tr><tr><td>Sequence-based reagent</td><td valign="top">sgRNA12-Fw</td><td>This paper</td><td/><td valign="top">CACCGACTCCAGTATAGCCTCGATG</td></tr><tr><td>Sequence-based reagent</td><td valign="top">sgRNA12-Re</td><td>This paper</td><td/><td valign="top">AAACCATCGAGGCTATACTGGAGTC</td></tr><tr><td>Commercial assay or kit</td><td>SuperScript IV First-Strand Synthesis System</td><td>Invitrogen</td><td>18091050</td><td/></tr><tr><td>Commercial assay or kit</td><td>iQ SYBR Supermix</td><td>Bio-Rad</td><td>170–8882</td><td/></tr><tr><td>Commercial assay or kit</td><td>Surveyor Mutation Detection Kit</td><td>IDT</td><td>706020</td><td/></tr><tr><td>Commercial assay or kit</td><td>MEGAscript T7 Transcription Kit</td><td>Invitrogen</td><td>AMB13345</td><td/></tr><tr><td>Commercial assay or kit</td><td>MEGAclear-96 Transcription Clean-Up Kit</td><td>Invitrogen</td><td>AM1909</td><td/></tr><tr><td>Commercial assay or kit</td><td>H and E staining Kit</td><td>Abcam</td><td>ab245880</td><td/></tr><tr><td>Commercial assay or kit</td><td>Pierce BCA protein assay kit</td><td>Thermo Fisher Scientific</td><td>23225</td><td/></tr><tr><td>Commercial assay or kit</td><td>DeadEnd Fluorometric TUNEL System</td><td>Promega</td><td>G3250</td><td/></tr><tr><td>Software, algorithm</td><td>ImageJ software</td><td>ImageJ <break/>(<ext-link ext-link-type="uri" xlink:href="https://imagej.net/">https://imagej.net/</ext-link>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>GraphPad <break/>Prism software</td><td>GraphPad Prism <break/>(<ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com/">http://www.graphpad.com/</ext-link>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td>Version 6.0</td></tr><tr><td>Software, algorithm</td><td>CFX Manager</td><td>CFX Manager (<ext-link ext-link-type="uri" xlink:href="http://www.bio-rad.com/en-eh/product/cfx-manager-software">http://www.bio-rad.com/en-eh/product/cfx-manager-software</ext-link>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017251">SCR_017251</ext-link></td><td/></tr><tr><td>Software, algorithm</td><td>NDP.view2 Viewing software</td><td>Hamamatsu Photonics (<ext-link ext-link-type="uri" xlink:href="https://www.hamamatsu.com/us/en/product/type/U12388-01/index.html">https://www.hamamatsu.com/us/en/product/type/U12388-01/index.html</ext-link>)</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017105">SCR_017105</ext-link></td><td/></tr><tr><td>Other</td><td>DAPI stain</td><td valign="top">Invitrogen</td><td valign="top">D1306</td><td>(14.3 μM)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>All animal protocols were approved by the Animal Care and Use Committee of the University of California San Diego. Wild-type C57BL/6J mice (Stock No: 000664; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI_3028467">MGI_3028467</ext-link>) and <italic>Pvalb<sup>Cre</sup></italic> mice (Stock No: 017320; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI_3590684">MGI_3590684</ext-link>) were purchased from The Jackson Laboratory.</p><p><italic>Map3k13</italic> knockout mice were generated in the UCSD Transgenic and Knockout Mouse Core, using CRISPR-Cas9 technology (<xref ref-type="bibr" rid="bib51">Ran et al., 2013</xref>). Briefly, sgRNA sequences targeted to the kinase domain were designed using online tools (<ext-link ext-link-type="uri" xlink:href="http://crispr.mit.edu">http://crispr.mit.edu</ext-link>) (Key Resources Table). The selected sgRNAs were annealed, and then cloned into PX330 backbone digested with BbsI. Effectiveness of sgRNAs was tested using Surveyor nuclease assay (Surveyor Mutation Detection Kit, IDT, 706020). To make sgRNAs, DNA fragments containing T7 promoter followed by sgRNA were first amplified using primers YJ12532-12535. The purified DNAs were then in vitro transcribed using MEGAscript T7 Transcription Kit (Invitrogen, AMB13345), and the resulting transcripts were purified using MEGAclear-96 Transcription Clean-Up Kit (Invitrogen, AM1909). The sgRNAs and Cas9 mRNA were injected into zygotes from C57BL6, which were then implanted into the CD1 surrogate mothers. Two KO mouse lines were obtained and the one containing a deletion of the entire kinase domain was used in this study. <italic>Map3k13<sup>fl</sup></italic> and <italic>Map3k12<sup>fl</sup></italic> mice were reported in <xref ref-type="bibr" rid="bib7">Chen et al., 2016b</xref>. <italic>Map3k12<sup>fl</sup></italic> mice were a kind gift of Dr. Lawrence B. Holzman (Univ. Penn). <italic>Celf2<sup>fl</sup></italic> mice were described previously (<xref ref-type="bibr" rid="bib6">Chen et al., 2016a</xref>). Primers for genotypes are listed in <xref ref-type="table" rid="table1">Table 1</xref>.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Primers used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Designation</th><th valign="top">5’−3’</th><th valign="top">PCR Products (bp)</th><th valign="top">Purpose</th></tr></thead><tbody><tr><td valign="top">YJ12516</td><td valign="top">CGACCTCAACTTGGATATCAGCC</td><td rowspan="2" valign="top">148 (<italic>Map2k7-L</italic>) <break/>100 (<italic>Map2k7-S</italic>)</td><td rowspan="2" valign="top">RT-PCR</td></tr><tr><td valign="top">YJ12517</td><td valign="top">GGAGCTCTCTGAGGATGGTGAGC</td></tr><tr><td valign="top">YJ12518</td><td valign="top">GCTTCTTTGCAGCTCCTTCGT</td><td rowspan="2" valign="top">201 (<italic>Actin</italic>)</td><td rowspan="2" valign="top">RT-PCR</td></tr><tr><td valign="top">YJ12519</td><td valign="top">CCTTCTGACCCATTCCCACC</td></tr><tr><td valign="top">YJ12520</td><td valign="top">TGGAGGAGGACAAACTGGTCA</td><td rowspan="3" valign="top">323 (Wild-type) <break/>~500 (Hipp11-DLK(iOE)) <break/>~600 (Hipp11-LZK(iOE))</td><td rowspan="3" valign="top">Genotyping</td></tr><tr><td valign="top">YJ12521</td><td valign="top">TTCCCTTTCTGCTTCATCTTGC</td></tr><tr><td valign="top">YJ12522</td><td valign="top">CATATATGGGCTATGAACTAATGACCCCGT</td></tr><tr><td valign="top">YJ12523</td><td valign="top">GATGATTGCTAGTCATGGAGTAGTAGG</td><td rowspan="2" valign="top">350 (Wild-type) <break/>500 (<italic>Map3k12<sup>fl/fl</sup></italic>)</td><td rowspan="2" valign="top">Genotyping</td></tr><tr><td valign="top">YJ12524</td><td valign="top">GGTGGTGTTATCATAGTTCCATCATG</td></tr><tr><td valign="top">YJ12525</td><td valign="top">ACATCTGGATCTGAAGACAGCCAGG</td><td rowspan="2" valign="top">~500 (Wild-type) <break/>~600 (<italic>Map3k13<sup>fl/fl</sup></italic>)</td><td rowspan="2" valign="top">Genotyping</td></tr><tr><td valign="top">YJ12526</td><td valign="top">AGGTGCGTTTTCATTCTTCTGGACC</td></tr><tr><td valign="top">YJ12527</td><td valign="top">GAGGTGTCTGCCGAACT</td><td rowspan="2" valign="top">370 (Wild-type) <break/>470 (<italic>Celf2<sup>fl/fl</sup></italic>)</td><td rowspan="2" valign="top">Genotyping</td></tr><tr><td valign="top">YJ12528</td><td valign="top">CACTCAGTCCCTGTTTGTAA</td></tr><tr><td valign="top">YJ12529</td><td valign="top">TGGCAGTGTGGAGACAGAAG</td><td rowspan="3" valign="top">720 (Wild-type) <break/>420 (<italic>Map3k13<sup>KO/KO</sup></italic>)</td><td rowspan="3" valign="top">Genotyping</td></tr><tr><td valign="top">YJ12530</td><td valign="top">CCTACCTGCCTTTCCCGTTG</td></tr><tr><td valign="top">YJ12531</td><td valign="top">TGCTCACCTGGGATCTGACTA</td></tr><tr><td valign="top">YJ12532</td><td valign="top">TTAATACGACTCACTATAGGGTGGCACTACAGGTCACATAC</td><td rowspan="2" valign="top">121</td><td rowspan="2" valign="top">sgRNA2 PCR</td></tr><tr><td valign="top">YJ12535</td><td valign="top">AAAAGCACCGACTCGGTGCC</td></tr><tr><td valign="top">YJ12533</td><td valign="top">TTAATACGACTCACTATAGGGGACCTCGTACAGCTGTCCGT</td><td rowspan="2" valign="top">121</td><td rowspan="2" valign="top">sgRNA5 PCR</td></tr><tr><td valign="top">YJ12535</td><td valign="top">AAAAGCACCGACTCGGTGCC</td></tr><tr><td valign="top">YJ12534</td><td valign="top">TTAATACGACTCACTATAGGGACTCCAGTATAGCCTCGATG</td><td rowspan="2" valign="top">121</td><td rowspan="2" valign="top">sgRNA12 PCR</td></tr><tr><td valign="top">YJ12535</td><td valign="top">AAAAGCACCGACTCGGTGCC</td></tr><tr><td valign="top">YJ12536</td><td valign="top">GGCCCAGGCCCATTATTGTG</td><td rowspan="2" valign="top">83 (<italic>Map2k7-L</italic>)</td><td rowspan="2" valign="top">qRT-PCR</td></tr><tr><td valign="top">YJ12537</td><td valign="top">GTTGGCCAGTGGGAGTTGCAG</td></tr><tr><td valign="top">YJ12538</td><td valign="top">GCCAAGCTGAAGCAGGAGAACC</td><td rowspan="2" valign="top">100 (<italic>Map2k7-S</italic>)</td><td rowspan="2" valign="top">qRT-PCR</td></tr><tr><td valign="top">YJ12539</td><td valign="top">CCAGTGGGAGTTGCAGGGTG</td></tr></tbody></table></table-wrap><p>Transgenic mice for inducible expression, Hipp11-DLK(iOE) and Hipp11-LZK(iOE), were made by Applied StemCell, Inc (Milpitas, CA), using TARGATT Technology (<xref ref-type="bibr" rid="bib62">Tasic et al., 2011</xref>). A mixture of plasmid pBT378-LSL-3X Flag-DLK-T2A-tdTomato, or pBT378-LSL-1X Flag-LZK-T2A-tdTomato DNA, and in vitro transcribed ϕC31 integrase mRNA was microinjected into the pronucleus of zygotes from a FVB strain that has the Att recombination landing site inserted in <italic>Hipp11</italic> locus (<xref ref-type="bibr" rid="bib23">Hippenmeyer et al., 2010</xref>), which were then implanted into the CD1 surrogate mothers. The founder heterozygous mice were bred three times to pure C57BL/6J (Stock No: 000664; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI_3028467">MGI_3028467</ext-link>) background.</p></sec><sec id="s4-2"><title>Histology and immunocytochemistry</title><p>Mice were transcardially perfused with 0.9% saline solution and then 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) (pH 7.2–7.4). Brains were dissected, post-fixed in 4% PFA overnight at 4°C, and then transferred to 30% sucrose in PBS, prior to embedding using O.C.T compound (Fisher Healthcare, 4585) on dry ice. A total of 25-μm-thick sagittal sections were collected on a cryostat (Leica, CM1850) into PBS with 0.01% NaN<sub>3</sub>. For histology analysis, free floating tissue sections were loaded to the slide, and then sequentially stained with hematoxylin and eosin (H and E staining Kit, abcam, ab245880). For immunostaining, free floating tissue sections were washed twice in PBS with 0.2% Triton X-100, blocked with 5% goat serum in PBS with 0.4% Triton X-100 for 2 hr at room temperature, then incubated with primary antibodies (Key Resources Table) diluted in PBS with 0.2% Triton X-100 and 2% goat serum overnight at 4°C. Alexa Fluor 488-conjugated and Alexa Fluor 647-conjugated secondary antibodies (Key Resources Table) were incubated for 2 hr at room temperature, followed by staining with DAPI (14.3 μM in PBS, Thermo Fisher Scientific, D1306) for 10 min. Stained sections were mounted with prolong diamond antifade mountant (Thermo Fisher Scientific, P36970).</p></sec><sec id="s4-3"><title>TUNEL staining</title><p>The DeadEnd Fluorometric TUNEL System (Promega, G3250) was used with a modified protocol. Free floating tissue sections were washed twice in PBS, and then loaded to the slide. The slides were dried at 65°C for 5 min, then immersed into PBS with 0.5% Triton X-100 and incubated at 85°C for 20 min, followed by three times rinsing with PBS. The slides were incubated with equilibration buffer at room temperature for 5 min, and then incubated with reaction mix (equilibration buffer: nucleotide mix: rTdT enzyme = 45:5:1) at 37°C for 1 hr in a humidity chamber. The reactions were stopped by incubating the slide with 2X saline-sodium citrate (SSC) buffer at room temperature for 10 min. After three washes with PBS, the slides were incubated with DAPI (14.3 μM in PBS) at room temperature for 15 min, followed by three washes with ddH<sub>2</sub>O, and then mounted with prolong diamond antifade mountant (Thermo Fisher Scientific, P36970).</p></sec><sec id="s4-4"><title>Image acquisition and analysis</title><p>The slides of H and E staining were scanned with Nanozoomer 2.0-HT digital slide scanner (Hamamatsu Photonics) in brightfield at 40X magnification. The images were processed using NDP.view2 Viewing software (Hamamatsu Photonics, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017105">SCR_017105</ext-link>) and ImageJ software (ImageJ, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link>). Fluorescence images of paired WT and mutant samples were acquired on a Zeiss LSM 710 confocal microscope at 40X magnification. The images were taken as Z-stack under identical settings, and the maximum intensity projection images (unless otherwise specified) were processed using ImageJ software (ImageJ, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link>). For image quantification, three midline parasagittal sections per brain and at least three brains per genotype of given age were analyzed and data was averaged. Cells were counted using the cell counter plugin for ImageJ (ImageJ, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link>). Analyses of cell numbers for Calbindin<sup>+</sup> PCs, p-c-Jun<sup>+</sup> PCs, dendrite swelling<sup>+</sup> PCs or cleaved caspase-3<sup>+</sup> PCs were performed by counting the soma of each PC in the entire lobules. The thickness of the molecular layer visualized by Calbindin staining was assessed for lobule V/VI in midline sections by measuring the perpendicular distance from the molecular layer-facing edge of a Purkinje cell soma to the outer edge of the molecular layer. Cerebellum area was calculated by outlining the perimeter of the outer edges of the sagittal sections of cerebellum. TUNEL<sup>+</sup> cells were counted by analyzing particles after adjustment of threshold and watershed. The particles with area larger than 8 μm<sup>2</sup> were measured. TUNEL<sup>+</sup> cell density was calculated the number of TUNEL<sup>+</sup> cells in entire cerebellum divided by entire cerebellum area. GFAP or IBA1 immunofluorescence intensity density was calculated by dividing the GFAP or IBA1 immunofluorescence intensity of entire cerebellum by the entire cerebellum area. For p-c-Jun immunofluorescence intensity quantification, about 30 sampling area surrounding a single p-c-Jun<sup>+</sup> nucleus (ROI being 347.543 μm<sup>2</sup>) per section were measured. For LZK immunofluorescence intensity quantification, about 30 sampling area surrounding a single soma of Purkinje cells (ROI being 352.943 μm<sup>2</sup>) were measured in the region of interest per section. Integrated density was averaged after subtraction of background signal and adjustment of threshold.</p></sec><sec id="s4-5"><title>Immunoprecipitation and western blotting</title><p>Dissected cerebella from mice of indicated age were homogenized in an appropriate volume of cell lysis buffer (50 mM Tris.Cl [pH 7.4], 1% Triton X-100, 0.1% SDS, 1 mM EDTA [pH 7.0], 150 mM NaCl, 1% n-Octyl β-D-glucopyranoside, 1 x protease inhibitor cocktail [Roche, 05892970001]) using TissueRuptor II (QIAGEN, 9002756), then lysed for 1 hr on ice, and cleared by centrifugation at 13,000 rpm for 10 min at 4°C. Supernatants were collected and protein concentrations were determined by Pierce BCA protein assay kit (Thermo Fisher Scientific, 23225). For immunoprecipitation experiments, antibody-bound beads were prepared using 2 μg rabbit anti-MAP3K13 polyclonal antibody (Sigma-Aldrich, HPA016497) in 800 μl of lysis buffer with 50 μl of 50% Protein G agarose bead slurry, with gentle rotation at 4°C for 1 hr. ~1 mg protein lysates were pre-cleared with 50 μl of 50% Protein G agarose bead slurry, then incubated with the antibody-bound beads overnight at 4℃. The beads were washed three times with lysis buffer, and then resuspended in 60 μl lysis buffer and 20 μl 4 x Laemmli Sample Buffer (Bio-RAD, 161–0747), heat shocked in a thermomixer (Eppendorf) at 95°C for 10 min and analyzed by western blotting. Immunoprecipitated samples were separated by SDS-PAGE using Any kD Mini-PROTEAN TGX Precast Protein Gels (Bio-Rad, 4569034), and then blotted to a PVDF membrane (0.2 μm, Bio-RAD, 1620177) by Mini Trans-Blot Cell (Bio-RAD, 170–3930) at 100 mA for 1 hr. Blots were blocked in 10% non-fat dry milk in PBST (PBS with 0.05% Tween-20) for 1 hr at room temperature, and then incubated with an appropriate concentration of primary antibody in 1% non-fat BSA in PBST at 4°C for overnight. Afterwards, the membrane was incubated with Horseradish Peroxidase (HRP)-conjugated secondary antibodies (Key Resources Table) in 1% non-fat BSA in PBST at room temperature for 1 hr, followed by detection using enhanced chemiluminescence (ECL) reagents (GE Healthcare, RPN2106).</p></sec><sec id="s4-6"><title>RNA extraction, RT-PCR, and qRT-PCR</title><p>Total RNA from mouse cerebellum was extracted using TRIzol (Invitrogen, 15596018) following the manufacturers’ protocols. First strand cDNA was reverse-transcribed using SuperScript IV (Invitrogen, 18091050). qPCR was run on Bio-Rad CFX96 Touch Real-Time PCR Detection System with iQ SYBR Supermix (Bio-Rad, 170–8882). Data were analyzed using CFX manager (CFX Manager, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017251">SCR_017251</ext-link>).</p></sec><sec id="s4-7"><title>Animal behavior tests</title><p>Mouse behavioral analysis was scored in a genotype blind manner following the protocol described in <xref ref-type="bibr" rid="bib20">Guyenet et al., 2010</xref>. Briefly, ledge walking, hind limb clasping, gait, and kyphosis were scored with a scale of 0–3 in each category, resulting in total score of 0–12 points for all four measures at P30, P45, P60, P75, P90, P105, and P120. A score of 0 represents absence of the relevant phenotype and three represents the most severe phenotype. Each test was performed three times to ensure reproducibility. For data analysis, the score was calculated for each measure by taking the mean of the three measurements in each mouse.</p></sec><sec id="s4-8"><title>Statistics</title><p>GraphPad Prism 6.0 (GraphPad Prism, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link>) was used for all statistical analysis. After assessing for normal distribution, statistical analyses between two groups were calculated with the two-tailed t-test for normally distributed data. For comparison of more than two groups, normally distributed data was calculated with a one-way ANOVA. Asterisks indicate significance with (<bold><sub>*</sub></bold>) p&lt;0.05, (<bold><sub>**</sub></bold>) p&lt;0.01, (<bold><sub>***</sub></bold>) p&lt;0.001, (<bold><sub>****</sub></bold>) p&lt;0.0001 for all data sets. Graphs show mean values ± standard error of the mean (SEM).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to our lab members for valuable discussions. We thank Drs. A D Chisholm, S L Ackerman and G Thomas for comments on the manuscript. We thank Dr. L Holzman (U Penn) for providing conditional deletion of DLK mice, UCSD Transgenic and Knockout Mouse Core for generating <italic>Map3k13<sup>KO</sup></italic> mice, and UCSD Neuroscience Microscopy Shared Facility (NS047101) for providing imaging support. We thank A Moore, E Xu, D Arakelyan and R Zarei for technical assistance. This work was supported by funds from Howard Hughes Medical Institute, the Craig H Neilsen Foundation, the Junior Seau Foundation, and the Kavli Institute of Brain and Mind at UCSD.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-63509-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>This study does not generate sequencing data, proteomic data, or diffraction data. Source data for immunofluorescence quantification, cell counts, and animal behaviors have been provided for Figures 1-7.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajith</surname> <given-names>S</given-names></name><name><surname>Gazzara</surname> <given-names>MR</given-names></name><name><surname>Cole</surname> <given-names>BS</given-names></name><name><surname>Shankarling</surname> <given-names>G</given-names></name><name><surname>Martinez</surname> <given-names>NM</given-names></name><name><surname>Mallory</surname> <given-names>MJ</given-names></name><name><surname>Lynch</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Position-dependent activity of CELF2 in the regulation of splicing and implications for signal-responsive regulation in T cells</article-title><source>RNA Biology</source><volume>13</volume><fpage>569</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1080/15476286.2016.1176663</pub-id><pub-id pub-id-type="pmid">27096301</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asghari Adib</surname> <given-names>E</given-names></name><name><surname>Smithson</surname> <given-names>LJ</given-names></name><name><surname>Collins</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An axonal stress response pathway: degenerative and regenerative signaling by DLK</article-title><source>Current Opinion in Neurobiology</source><volume>53</volume><fpage>110</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.07.002</pub-id><pub-id pub-id-type="pmid">30053694</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asrican</surname> <given-names>B</given-names></name><name><surname>Augustine</surname> <given-names>GJ</given-names></name><name><surname>Berglund</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>S</given-names></name><name><surname>Chow</surname> <given-names>N</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name><name><surname>Feng</surname> <given-names>G</given-names></name><name><surname>Gloss</surname> <given-names>B</given-names></name><name><surname>Hira</surname> <given-names>R</given-names></name><name><surname>Hoffmann</surname> <given-names>C</given-names></name><name><surname>Kasai</surname> <given-names>H</given-names></name><name><surname>Katarya</surname> <given-names>M</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Kudolo</surname> <given-names>J</given-names></name><name><surname>Lee</surname> <given-names>LM</given-names></name><name><surname>Lo</surname> <given-names>SQ</given-names></name><name><surname>Mancuso</surname> <given-names>J</given-names></name><name><surname>Matsuzaki</surname> <given-names>M</given-names></name><name><surname>Nakajima</surname> <given-names>R</given-names></name><name><surname>Qiu</surname> <given-names>L</given-names></name><name><surname>Tan</surname> <given-names>G</given-names></name><name><surname>Tang</surname> <given-names>Y</given-names></name><name><surname>Ting</surname> <given-names>JT</given-names></name><name><surname>Tsuda</surname> <given-names>S</given-names></name><name><surname>Wen</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Zhao</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Next-generation transgenic mice for optogenetic analysis of neural circuits</article-title><source>Frontiers in Neural Circuits</source><volume>7</volume><elocation-id>160</elocation-id><pub-id pub-id-type="doi">10.3389/fncir.2013.00160</pub-id><pub-id pub-id-type="pmid">24324405</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Björkblom</surname> <given-names>B</given-names></name><name><surname>Ostman</surname> <given-names>N</given-names></name><name><surname>Hongisto</surname> <given-names>V</given-names></name><name><surname>Komarovski</surname> <given-names>V</given-names></name><name><surname>Filén</surname> <given-names>JJ</given-names></name><name><surname>Nyman</surname> <given-names>TA</given-names></name><name><surname>Kallunki</surname> <given-names>T</given-names></name><name><surname>Courtney</surname> <given-names>MJ</given-names></name><name><surname>Coffey</surname> <given-names>ET</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector</article-title><source>Journal of Neuroscience</source><volume>25</volume><fpage>6350</fpage><lpage>6361</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1517-05.2005</pub-id><pub-id pub-id-type="pmid">16000625</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>L</given-names></name><name><surname>Jones</surname> <given-names>Y</given-names></name><name><surname>Ellisman</surname> <given-names>MH</given-names></name><name><surname>Goldstein</surname> <given-names>LS</given-names></name><name><surname>Karin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins</article-title><source>Developmental Cell</source><volume>4</volume><fpage>521</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1016/S1534-5807(03)00094-7</pub-id><pub-id pub-id-type="pmid">12689591</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Wei</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Rosenfeld</surname> <given-names>MG</given-names></name><name><surname>Fu</surname> <given-names>XD</given-names></name><name><surname>Chisholm</surname> <given-names>AD</given-names></name><name><surname>Jin</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>CELF RNA binding proteins promote axon regeneration in <italic>C. elegans</italic> and mammals through alternative splicing of Syntaxins</article-title><source>eLife</source><volume>5</volume><elocation-id>e16072</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.16072</pub-id><pub-id pub-id-type="pmid">27253061</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Geoffroy</surname> <given-names>CG</given-names></name><name><surname>Wong</surname> <given-names>HN</given-names></name><name><surname>Tress</surname> <given-names>O</given-names></name><name><surname>Nguyen</surname> <given-names>MT</given-names></name><name><surname>Holzman</surname> <given-names>LB</given-names></name><name><surname>Jin</surname> <given-names>Y</given-names></name><name><surname>Zheng</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Leucine Zipper-bearing kinase promotes axon growth in mammalian central nervous system neurons</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>31482</elocation-id><pub-id pub-id-type="doi">10.1038/srep31482</pub-id><pub-id pub-id-type="pmid">27511108</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Geoffroy</surname> <given-names>CG</given-names></name><name><surname>Meves</surname> <given-names>JM</given-names></name><name><surname>Narang</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Nguyen</surname> <given-names>MT</given-names></name><name><surname>Khai</surname> <given-names>VS</given-names></name><name><surname>Kong</surname> <given-names>X</given-names></name><name><surname>Steinke</surname> <given-names>CL</given-names></name><name><surname>Carolino</surname> <given-names>KI</given-names></name><name><surname>Elzière</surname> <given-names>L</given-names></name><name><surname>Goldberg</surname> <given-names>MP</given-names></name><name><surname>Jin</surname> <given-names>Y</given-names></name><name><surname>Zheng</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Leucine Zipper-Bearing kinase is a critical regulator of astrocyte reactivity in the adult mammalian CNS</article-title><source>Cell Reports</source><volume>22</volume><fpage>3587</fpage><lpage>3597</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.02.102</pub-id><pub-id pub-id-type="pmid">29590625</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>XS</given-names></name><name><surname>Li</surname> <given-names>MS</given-names></name><name><surname>Du</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>QY</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Yan</surname> <given-names>SY</given-names></name><name><surname>Yu</surname> <given-names>DM</given-names></name><name><surname>Deng</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neuronal apoptosis in the developing cerebellum</article-title><source>Anatomia, Histologia, Embryologia</source><volume>40</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1111/j.1439-0264.2010.01033.x</pub-id><pub-id pub-id-type="pmid">21231956</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname> <given-names>CA</given-names></name><name><surname>Wairkar</surname> <given-names>YP</given-names></name><name><surname>Johnson</surname> <given-names>SL</given-names></name><name><surname>DiAntonio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Highwire restrains synaptic growth by attenuating a MAP kinase signal</article-title><source>Neuron</source><volume>51</volume><fpage>57</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.05.026</pub-id><pub-id pub-id-type="pmid">16815332</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cupolillo</surname> <given-names>D</given-names></name><name><surname>Hoxha</surname> <given-names>E</given-names></name><name><surname>Faralli</surname> <given-names>A</given-names></name><name><surname>De Luca</surname> <given-names>A</given-names></name><name><surname>Rossi</surname> <given-names>F</given-names></name><name><surname>Tempia</surname> <given-names>F</given-names></name><name><surname>Carulli</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Autistic-Like traits and cerebellar dysfunction in purkinje cell PTEN Knock-Out mice</article-title><source>Neuropsychopharmacology</source><volume>41</volume><fpage>1457</fpage><lpage>1466</lpage><pub-id pub-id-type="doi">10.1038/npp.2015.339</pub-id><pub-id pub-id-type="pmid">26538449</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cvetanovic</surname> <given-names>M</given-names></name><name><surname>Ingram</surname> <given-names>M</given-names></name><name><surname>Orr</surname> <given-names>H</given-names></name><name><surname>Opal</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1</article-title><source>Neuroscience</source><volume>289</volume><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.01.003</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehmelt</surname> <given-names>L</given-names></name><name><surname>Halpain</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The MAP2/Tau family of microtubule-associated proteins</article-title><source>Genome Biology</source><volume>6</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/gb-2004-6-1-204</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmore</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Apoptosis: a review of programmed cell death</article-title><source>Toxicologic Pathology</source><volume>35</volume><fpage>495</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1080/01926230701320337</pub-id><pub-id pub-id-type="pmid">17562483</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farley</surname> <given-names>MM</given-names></name><name><surname>Watkins</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Intrinsic neuronal stress response pathways in injury and disease</article-title><source>Annual Review of Pathology: Mechanisms of Disease</source><volume>13</volume><fpage>93</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1146/annurev-pathol-012414-040354</pub-id><pub-id pub-id-type="pmid">29414247</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gdalyahu</surname> <given-names>A</given-names></name><name><surname>Ghosh</surname> <given-names>I</given-names></name><name><surname>Levy</surname> <given-names>T</given-names></name><name><surname>Sapir</surname> <given-names>T</given-names></name><name><surname>Sapoznik</surname> <given-names>S</given-names></name><name><surname>Fishler</surname> <given-names>Y</given-names></name><name><surname>Azoulai</surname> <given-names>D</given-names></name><name><surname>Reiner</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>DCX, a new mediator of the JNK pathway</article-title><source>The EMBO Journal</source><volume>23</volume><fpage>823</fpage><lpage>832</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7600079</pub-id><pub-id pub-id-type="pmid">14765123</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwani</surname> <given-names>S</given-names></name><name><surname>Fernandez</surname> <given-names>C</given-names></name><name><surname>Acton</surname> <given-names>PJ</given-names></name><name><surname>Buggia-Prevot</surname> <given-names>V</given-names></name><name><surname>McReynolds</surname> <given-names>ML</given-names></name><name><surname>Ma</surname> <given-names>J</given-names></name><name><surname>Hu</surname> <given-names>CH</given-names></name><name><surname>Hamby</surname> <given-names>ME</given-names></name><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>Le</surname> <given-names>K</given-names></name><name><surname>Soth</surname> <given-names>MJ</given-names></name><name><surname>Jones</surname> <given-names>P</given-names></name><name><surname>Ray</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Dual leucine zipper kinase is constitutively active in the adult mouse brain and has both Stress-Induced and homeostatic functions</article-title><source>International Journal of Molecular Sciences</source><volume>21</volume><elocation-id>4849</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21144849</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grill</surname> <given-names>B</given-names></name><name><surname>Murphey</surname> <given-names>RK</given-names></name><name><surname>Borgen</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The PHR proteins: intracellular signaling hubs in neuronal development and axon degeneration</article-title><source>Neural Development</source><volume>11</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1186/s13064-016-0063-0</pub-id><pub-id pub-id-type="pmid">27008623</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname> <given-names>A</given-names></name><name><surname>McDonnell</surname> <given-names>JM</given-names></name><name><surname>Korsmeyer</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>BCL-2 family members and the mitochondria in apoptosis</article-title><source>Genes &amp; Development</source><volume>13</volume><fpage>1899</fpage><lpage>1911</lpage><pub-id pub-id-type="doi">10.1101/gad.13.15.1899</pub-id><pub-id pub-id-type="pmid">10444588</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyenet</surname> <given-names>SJ</given-names></name><name><surname>Furrer</surname> <given-names>SA</given-names></name><name><surname>Damian</surname> <given-names>VM</given-names></name><name><surname>Baughan</surname> <given-names>TD</given-names></name><name><surname>La Spada</surname> <given-names>AR</given-names></name><name><surname>Garden</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia</article-title><source>Journal of Visualized Experiments</source><volume>39</volume><elocation-id>1787</elocation-id><pub-id pub-id-type="doi">10.3791/1787</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname> <given-names>ST</given-names></name><name><surname>Meera</surname> <given-names>P</given-names></name><name><surname>Otis</surname> <given-names>TS</given-names></name><name><surname>Pulst</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Changes in purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2</article-title><source>Human Molecular Genetics</source><volume>22</volume><fpage>271</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds427</pub-id><pub-id pub-id-type="pmid">23087021</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hippenmeyer</surname> <given-names>S</given-names></name><name><surname>Vrieseling</surname> <given-names>E</given-names></name><name><surname>Sigrist</surname> <given-names>M</given-names></name><name><surname>Portmann</surname> <given-names>T</given-names></name><name><surname>Laengle</surname> <given-names>C</given-names></name><name><surname>Ladle</surname> <given-names>DR</given-names></name><name><surname>Arber</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A developmental switch in the response of DRG neurons to ETS transcription factor signaling</article-title><source>PLOS Biology</source><volume>3</volume><elocation-id>e159</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0030159</pub-id><pub-id pub-id-type="pmid">15836427</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hippenmeyer</surname> <given-names>S</given-names></name><name><surname>Youn</surname> <given-names>YH</given-names></name><name><surname>Moon</surname> <given-names>HM</given-names></name><name><surname>Miyamichi</surname> <given-names>K</given-names></name><name><surname>Zong</surname> <given-names>H</given-names></name><name><surname>Wynshaw-Boris</surname> <given-names>A</given-names></name><name><surname>Luo</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genetic mosaic dissection of Lis1 and Ndel1 in neuronal migration</article-title><source>Neuron</source><volume>68</volume><fpage>695</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.09.027</pub-id><pub-id pub-id-type="pmid">21092859</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname> <given-names>S</given-names></name><name><surname>Kawaguchi</surname> <given-names>A</given-names></name><name><surname>Suenaga</surname> <given-names>J</given-names></name><name><surname>Ono</surname> <given-names>M</given-names></name><name><surname>Cui</surname> <given-names>DF</given-names></name><name><surname>Ohno</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Expression of MUK/DLK/ ZPK, an activator of the JNK pathway, in the nervous systems of the developing mouse embryo</article-title><source>Gene Expression Patterns : GEP</source><volume>5</volume><fpage>517</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/j.modgep.2004.12.002</pub-id><pub-id pub-id-type="pmid">15749080</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname> <given-names>S</given-names></name><name><surname>Cui</surname> <given-names>DF</given-names></name><name><surname>Miyata</surname> <given-names>T</given-names></name><name><surname>Ogawa</surname> <given-names>M</given-names></name><name><surname>Kiyonari</surname> <given-names>H</given-names></name><name><surname>Suda</surname> <given-names>Y</given-names></name><name><surname>Aizawa</surname> <given-names>S</given-names></name><name><surname>Banba</surname> <given-names>Y</given-names></name><name><surname>Ohno</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The c-Jun N-terminal kinase activator dual leucine zipper kinase regulates axon growth and neuronal migration in the developing cerebral cortex</article-title><source>The Journal of Neuroscience</source><volume>26</volume><fpage>11992</fpage><lpage>12002</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2272-06.2006</pub-id><pub-id pub-id-type="pmid">17108173</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname> <given-names>S</given-names></name><name><surname>Banba</surname> <given-names>Y</given-names></name><name><surname>Satake</surname> <given-names>T</given-names></name><name><surname>Ohno</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Axon formation in neocortical neurons depends on Stage-Specific regulation of microtubule stability by the dual leucine zipper kinase– c-Jun N-Terminal Kinase Pathway</article-title><source>The Journal of Neuroscience</source><volume>31</volume><fpage>6468</fpage><lpage>6480</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5038-10.2011</pub-id><pub-id pub-id-type="pmid">21525288</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname> <given-names>SM</given-names></name><name><surname>Collura</surname> <given-names>KM</given-names></name><name><surname>Ketschek</surname> <given-names>A</given-names></name><name><surname>Noma</surname> <given-names>K</given-names></name><name><surname>Ferguson</surname> <given-names>TA</given-names></name><name><surname>Jin</surname> <given-names>Y</given-names></name><name><surname>Gallo</surname> <given-names>G</given-names></name><name><surname>Thomas</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Palmitoylation controls DLK localization, interactions and activity to ensure effective axonal injury signaling</article-title><source>PNAS</source><volume>113</volume><fpage>763</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1073/pnas.1514123113</pub-id><pub-id pub-id-type="pmid">26719418</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollville</surname> <given-names>E</given-names></name><name><surname>Romero</surname> <given-names>SE</given-names></name><name><surname>Deshmukh</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Apoptotic cell death regulation in neurons</article-title><source>The FEBS Journal</source><volume>286</volume><fpage>3276</fpage><lpage>3298</lpage><pub-id pub-id-type="doi">10.1111/febs.14970</pub-id><pub-id pub-id-type="pmid">31230407</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoskison</surname> <given-names>MM</given-names></name><name><surname>Yanagawa</surname> <given-names>Y</given-names></name><name><surname>Obata</surname> <given-names>K</given-names></name><name><surname>Shuttleworth</surname> <given-names>CW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Calcium-dependent NMDA-induced dendritic injury and MAP2 loss in acute hippocampal slices</article-title><source>Neuroscience</source><volume>145</volume><fpage>66</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.11.034</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotamisligil</surname> <given-names>GS</given-names></name><name><surname>Davis</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cell Signaling and Stress Responses</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>8</volume><elocation-id>a006072</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a006072</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>YA</given-names></name><name><surname>Zhou</surname> <given-names>B</given-names></name><name><surname>Wernig</surname> <given-names>M</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and aβ secretion</article-title><source>Cell</source><volume>168</volume><fpage>427</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.12.044</pub-id><pub-id pub-id-type="pmid">28111074</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname> <given-names>A</given-names></name><name><surname>Hasegawa</surname> <given-names>K</given-names></name><name><surname>Masaki</surname> <given-names>M</given-names></name><name><surname>Moriguchi</surname> <given-names>T</given-names></name><name><surname>Nishida</surname> <given-names>E</given-names></name><name><surname>Kozutsumi</surname> <given-names>Y</given-names></name><name><surname>Oka</surname> <given-names>S</given-names></name><name><surname>Kawasaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2001">2001a</year><article-title>Mixed lineage kinase LZK forms a functional signaling complex with JIP-1, a scaffold protein of the c-Jun NH(2)-terminal kinase pathway</article-title><source>Journal of Biochemistry</source><volume>130</volume><fpage>773</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a003048</pub-id><pub-id pub-id-type="pmid">11726277</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname> <given-names>A</given-names></name><name><surname>Masaki</surname> <given-names>M</given-names></name><name><surname>Kozutsumi</surname> <given-names>Y</given-names></name><name><surname>Oka</surname> <given-names>S</given-names></name><name><surname>Kawasaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2001">2001b</year><article-title>Identification and characterization of functional domains in a mixed lineage kinase LZK</article-title><source>FEBS Letters</source><volume>488</volume><fpage>190</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(00)02432-7</pub-id><pub-id pub-id-type="pmid">11163770</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1984">1984</year><source>The Cerebellum and Neural Control</source><publisher-name>Raven press</publisher-name></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname> <given-names>A</given-names></name><name><surname>Horiuchi</surname> <given-names>M</given-names></name><name><surname>Wakayama</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Bannerman</surname> <given-names>P</given-names></name><name><surname>Pleasure</surname> <given-names>D</given-names></name><name><surname>Itoh</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ZPK/DLK, a mitogen-activated protein kinase kinase kinase, is a critical mediator of programmed cell death of motoneurons</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>7223</fpage><lpage>7228</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5947-10.2011</pub-id><pub-id pub-id-type="pmid">21593306</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname> <given-names>T</given-names></name><name><surname>Horiuchi</surname> <given-names>M</given-names></name><name><surname>Ikeda</surname> <given-names>RH</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Bannerman</surname> <given-names>P</given-names></name><name><surname>Pleasure</surname> <given-names>D</given-names></name><name><surname>Penninger</surname> <given-names>JM</given-names></name><name><surname>Tournier</surname> <given-names>C</given-names></name><name><surname>Itoh</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>ZPK/DLK and MKK4 form the critical gateway to axotomy-induced motoneuron death in neonates</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>10729</fpage><lpage>10742</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0539-14.2014</pub-id><pub-id pub-id-type="pmid">25100604</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>Y</given-names></name><name><surname>Zheng</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multitasking: Dual Leucine Zipper-Bearing kinases in Neuronal Development andStress Management</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>35</volume><fpage>501</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100617-062644</pub-id><pub-id pub-id-type="pmid">31590586</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joy</surname> <given-names>MT</given-names></name><name><surname>Ben Assayag</surname> <given-names>E</given-names></name><name><surname>Shabashov-Stone</surname> <given-names>D</given-names></name><name><surname>Liraz-Zaltsman</surname> <given-names>S</given-names></name><name><surname>Mazzitelli</surname> <given-names>J</given-names></name><name><surname>Arenas</surname> <given-names>M</given-names></name><name><surname>Abduljawad</surname> <given-names>N</given-names></name><name><surname>Kliper</surname> <given-names>E</given-names></name><name><surname>Korczyn</surname> <given-names>AD</given-names></name><name><surname>Thareja</surname> <given-names>NS</given-names></name><name><surname>Kesner</surname> <given-names>EL</given-names></name><name><surname>Zhou</surname> <given-names>M</given-names></name><name><surname>Huang</surname> <given-names>S</given-names></name><name><surname>Silva</surname> <given-names>TK</given-names></name><name><surname>Katz</surname> <given-names>N</given-names></name><name><surname>Bornstein</surname> <given-names>NM</given-names></name><name><surname>Silva</surname> <given-names>AJ</given-names></name><name><surname>Shohami</surname> <given-names>E</given-names></name><name><surname>Carmichael</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CCR5 is a therapeutic target for recovery after stroke and traumatic brain injury</article-title><source>Cell</source><volume>176</volume><fpage>1143</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.01.044</pub-id><pub-id pub-id-type="pmid">30794775</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lattke</surname> <given-names>M</given-names></name><name><surname>Reichel</surname> <given-names>SN</given-names></name><name><surname>Magnutzki</surname> <given-names>A</given-names></name><name><surname>Abaei</surname> <given-names>A</given-names></name><name><surname>Rasche</surname> <given-names>V</given-names></name><name><surname>Walther</surname> <given-names>P</given-names></name><name><surname>Calado</surname> <given-names>DP</given-names></name><name><surname>Ferger</surname> <given-names>B</given-names></name><name><surname>Wirth</surname> <given-names>T</given-names></name><name><surname>Baumann</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transient IKK2 activation in astrocytes initiates selective non-cell-autonomous neurodegeneration</article-title><source>Molecular Neurodegeneration</source><volume>12</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-017-0157-0</pub-id><pub-id pub-id-type="pmid">28193238</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Pichon</surname> <given-names>CE</given-names></name><name><surname>Meilandt</surname> <given-names>WJ</given-names></name><name><surname>Dominguez</surname> <given-names>S</given-names></name><name><surname>Solanoy</surname> <given-names>H</given-names></name><name><surname>Lin</surname> <given-names>H</given-names></name><name><surname>Ngu</surname> <given-names>H</given-names></name><name><surname>Gogineni</surname> <given-names>A</given-names></name><name><surname>Sengupta Ghosh</surname> <given-names>A</given-names></name><name><surname>Jiang</surname> <given-names>Z</given-names></name><name><surname>Lee</surname> <given-names>S-H</given-names></name><name><surname>Maloney</surname> <given-names>J</given-names></name><name><surname>Gandham</surname> <given-names>VD</given-names></name><name><surname>Pozniak</surname> <given-names>CD</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Siu</surname> <given-names>M</given-names></name><name><surname>Patel</surname> <given-names>S</given-names></name><name><surname>Modrusan</surname> <given-names>Z</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Rudhard</surname> <given-names>Y</given-names></name><name><surname>Baca</surname> <given-names>M</given-names></name><name><surname>Gustafson</surname> <given-names>A</given-names></name><name><surname>Kaminker</surname> <given-names>J</given-names></name><name><surname>Carano</surname> <given-names>RAD</given-names></name><name><surname>Huang</surname> <given-names>EJ</given-names></name><name><surname>Foreman</surname> <given-names>O</given-names></name><name><surname>Weimer</surname> <given-names>R</given-names></name><name><surname>Scearce-Levie</surname> <given-names>K</given-names></name><name><surname>Lewcock</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease</article-title><source>Science Translational Medicine</source><volume>9</volume><elocation-id>eaag0394</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aag0394</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewcock</surname> <given-names>JW</given-names></name><name><surname>Genoud</surname> <given-names>N</given-names></name><name><surname>Lettieri</surname> <given-names>K</given-names></name><name><surname>Pfaff</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The ubiquitin ligase Phr1 regulates axon outgrowth through modulation of microtubule dynamics</article-title><source>Neuron</source><volume>56</volume><fpage>604</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.09.009</pub-id><pub-id pub-id-type="pmid">18031680</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Lee</surname> <given-names>JW</given-names></name><name><surname>Ackerman</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mutations in the Microtubule-Associated protein 1A (Map1a) Gene cause purkinje cell degeneration</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>4587</fpage><lpage>4598</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2757-14.2015</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobsiger</surname> <given-names>CS</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease</article-title><source>Nature Neuroscience</source><volume>10</volume><fpage>1355</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1038/nn1988</pub-id><pub-id pub-id-type="pmid">17965655</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname> <given-names>NM</given-names></name><name><surname>Agosto</surname> <given-names>L</given-names></name><name><surname>Qiu</surname> <given-names>J</given-names></name><name><surname>Mallory</surname> <given-names>MJ</given-names></name><name><surname>Gazzara</surname> <given-names>MR</given-names></name><name><surname>Barash</surname> <given-names>Y</given-names></name><name><surname>Fu</surname> <given-names>XD</given-names></name><name><surname>Lynch</surname> <given-names>KW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation</article-title><source>Genes &amp; Development</source><volume>29</volume><fpage>2054</fpage><lpage>2066</lpage><pub-id pub-id-type="doi">10.1101/gad.267245.115</pub-id><pub-id pub-id-type="pmid">26443849</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merritt</surname> <given-names>SE</given-names></name><name><surname>Mata</surname> <given-names>M</given-names></name><name><surname>Nihalani</surname> <given-names>D</given-names></name><name><surname>Zhu</surname> <given-names>C</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Holzman</surname> <given-names>LB</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The mixed lineage kinase DLK utilizes MKK7 and not MKK4 as substrate</article-title><source>Journal of Biological Chemistry</source><volume>274</volume><fpage>10195</fpage><lpage>10202</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.15.10195</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakata</surname> <given-names>K</given-names></name><name><surname>Abrams</surname> <given-names>B</given-names></name><name><surname>Grill</surname> <given-names>B</given-names></name><name><surname>Goncharov</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Chisholm</surname> <given-names>AD</given-names></name><name><surname>Jin</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title> Regulation of a DLK-1 and p38 MAP kinase pathway by the ubiquitin ligase RPM-1 is required for presynaptic development</article-title><source>Cell</source><volume>120</volume><fpage>407</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.12.017</pub-id><pub-id pub-id-type="pmid">15707898</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nihalani</surname> <given-names>D</given-names></name><name><surname>Merritt</surname> <given-names>S</given-names></name><name><surname>Holzman</surname> <given-names>LB</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Identification of structural and functional domains in mixed lineage kinase dual leucine Zipper-bearing kinase required for complex formation and Stress-activated protein kinase activation</article-title><source>Journal of Biological Chemistry</source><volume>275</volume><fpage>7273</fpage><lpage>7279</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.10.7273</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Palay</surname> <given-names>SL</given-names></name><name><surname>Chan-Palay</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="1974">1974</year><source>Cerebellar Cortex: Cytology and Organization</source><publisher-name>Springer</publisher-name></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pozniak</surname> <given-names>CD</given-names></name><name><surname>Sengupta Ghosh</surname> <given-names>A</given-names></name><name><surname>Gogineni</surname> <given-names>A</given-names></name><name><surname>Hanson</surname> <given-names>JE</given-names></name><name><surname>Lee</surname> <given-names>S-H</given-names></name><name><surname>Larson</surname> <given-names>JL</given-names></name><name><surname>Solanoy</surname> <given-names>H</given-names></name><name><surname>Bustos</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Ngu</surname> <given-names>H</given-names></name><name><surname>Jubb</surname> <given-names>AM</given-names></name><name><surname>Ayalon</surname> <given-names>G</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Scearce-Levie</surname> <given-names>K</given-names></name><name><surname>Zhou</surname> <given-names>Q</given-names></name><name><surname>Weimer</surname> <given-names>RM</given-names></name><name><surname>Kirkpatrick</surname> <given-names>DS</given-names></name><name><surname>Lewcock</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration</article-title><source>Journal of Experimental Medicine</source><volume>210</volume><fpage>2553</fpage><lpage>2567</lpage><pub-id pub-id-type="doi">10.1084/jem.20122832</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ran</surname> <given-names>FA</given-names></name><name><surname>Hsu</surname> <given-names>PD</given-names></name><name><surname>Wright</surname> <given-names>J</given-names></name><name><surname>Agarwala</surname> <given-names>V</given-names></name><name><surname>Scott</surname> <given-names>DA</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Genome engineering using the CRISPR-Cas9 system</article-title><source>Nature Protocols</source><volume>8</volume><fpage>2281</fpage><lpage>2308</lpage><pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id><pub-id pub-id-type="pmid">24157548</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakuma</surname> <given-names>H</given-names></name><name><surname>Ikeda</surname> <given-names>A</given-names></name><name><surname>Oka</surname> <given-names>S</given-names></name><name><surname>Kozutsumi</surname> <given-names>Y</given-names></name><name><surname>Zanetta</surname> <given-names>J-P</given-names></name><name><surname>Kawasaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Molecular cloning and functional expression of a cDNA encoding a new member of mixed lineage protein kinase from human brain</article-title><source>Journal of Biological Chemistry</source><volume>272</volume><fpage>28622</fpage><lpage>28629</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.45.28622</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schellino</surname> <given-names>R</given-names></name><name><surname>Boido</surname> <given-names>M</given-names></name><name><surname>Vercelli</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>JNK signaling pathway involvement in spinal cord neuron development and death</article-title><source>Cells</source><volume>8</volume><elocation-id>1576</elocation-id><pub-id pub-id-type="doi">10.3390/cells8121576</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta Ghosh</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Pozniak</surname> <given-names>CD</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Watts</surname> <given-names>RJ</given-names></name><name><surname>Lewcock</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity</article-title><source>Journal of Cell Biology</source><volume>194</volume><fpage>751</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1083/jcb.201103153</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname> <given-names>JE</given-names></name><name><surname>Cho</surname> <given-names>Y</given-names></name><name><surname>Beirowski</surname> <given-names>B</given-names></name><name><surname>Milbrandt</surname> <given-names>J</given-names></name><name><surname>Cavalli</surname> <given-names>V</given-names></name><name><surname>DiAntonio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration</article-title><source>Neuron</source><volume>74</volume><fpage>1015</fpage><lpage>1022</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.04.028</pub-id><pub-id pub-id-type="pmid">22726832</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname> <given-names>JE</given-names></name><name><surname>Ha</surname> <given-names>H</given-names></name><name><surname>Kim</surname> <given-names>YK</given-names></name><name><surname>Cho</surname> <given-names>Y</given-names></name><name><surname>DiAntonio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DLK regulates a distinctive transcriptional regeneration program after peripheral nerve injury</article-title><source>Neurobiology of Disease</source><volume>127</volume><fpage>178</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2019.02.001</pub-id><pub-id pub-id-type="pmid">30735704</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simard-Bisson</surname> <given-names>C</given-names></name><name><surname>Bidoggia</surname> <given-names>J</given-names></name><name><surname>Larouche</surname> <given-names>D</given-names></name><name><surname>Guérin</surname> <given-names>SL</given-names></name><name><surname>Blouin</surname> <given-names>R</given-names></name><name><surname>Hirai</surname> <given-names>S-I</given-names></name><name><surname>Germain</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A role for DLK in microtubule reorganization to the cell periphery and in the maintenance of desmosomal and tight junction integrity</article-title><source>Journal of Investigative Dermatology</source><volume>137</volume><fpage>132</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2016.07.035</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siu</surname> <given-names>M</given-names></name><name><surname>Sengupta Ghosh</surname> <given-names>A</given-names></name><name><surname>Lewcock</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dual leucine zipper kinase inhibitors for the treatment of neurodegeneration</article-title><source>Journal of Medicinal Chemistry</source><volume>61</volume><fpage>8078</fpage><lpage>8087</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.8b00370</pub-id><pub-id pub-id-type="pmid">29863360</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suenaga</surname> <given-names>J</given-names></name><name><surname>Cui</surname> <given-names>DF</given-names></name><name><surname>Yamamoto</surname> <given-names>I</given-names></name><name><surname>Ohno</surname> <given-names>S</given-names></name><name><surname>Hirai</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Developmental changes in the expression pattern of the JNK activator kinase MUK/DLK/ZPK and active JNK in the mouse cerebellum</article-title><source>Cell and Tissue Research</source><volume>325</volume><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1007/s00441-006-0164-x</pub-id><pub-id pub-id-type="pmid">16520976</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname> <given-names>DW</given-names></name><name><surname>Frey</surname> <given-names>E</given-names></name><name><surname>Walker</surname> <given-names>LJ</given-names></name><name><surname>Milbrandt</surname> <given-names>J</given-names></name><name><surname>DiAntonio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>DLK activation synergizes with mitochondrial dysfunction to downregulate axon survival factors and promote SARM1-Dependent axon degeneration</article-title><source>Molecular Neurobiology</source><volume>57</volume><fpage>1146</fpage><lpage>1158</lpage><pub-id pub-id-type="doi">10.1007/s12035-019-01796-2</pub-id><pub-id pub-id-type="pmid">31696428</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tararuk</surname> <given-names>T</given-names></name><name><surname>Ostman</surname> <given-names>N</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Björkblom</surname> <given-names>B</given-names></name><name><surname>Padzik</surname> <given-names>A</given-names></name><name><surname>Zdrojewska</surname> <given-names>J</given-names></name><name><surname>Hongisto</surname> <given-names>V</given-names></name><name><surname>Herdegen</surname> <given-names>T</given-names></name><name><surname>Konopka</surname> <given-names>W</given-names></name><name><surname>Courtney</surname> <given-names>MJ</given-names></name><name><surname>Coffey</surname> <given-names>ET</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length</article-title><source>Journal of Cell Biology</source><volume>173</volume><fpage>265</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1083/jcb.200511055</pub-id><pub-id pub-id-type="pmid">16618812</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tasic</surname> <given-names>B</given-names></name><name><surname>Hippenmeyer</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Gamboa</surname> <given-names>M</given-names></name><name><surname>Zong</surname> <given-names>H</given-names></name><name><surname>Chen-Tsai</surname> <given-names>Y</given-names></name><name><surname>Luo</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Site-specific integrase-mediated transgenesis in mice via pronuclear injection</article-title><source>PNAS</source><volume>108</volume><fpage>7902</fpage><lpage>7907</lpage><pub-id pub-id-type="doi">10.1073/pnas.1019507108</pub-id><pub-id pub-id-type="pmid">21464299</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tedeschi</surname> <given-names>A</given-names></name><name><surname>Bradke</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The DLK signalling pathway--a double-edged sword in neural development and regeneration</article-title><source>EMBO Reports</source><volume>14</volume><fpage>605</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1038/embor.2013.64</pub-id><pub-id pub-id-type="pmid">23681442</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>GM</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>MAPK cascade signalling and synaptic plasticity</article-title><source>Nature Reviews Neuroscience</source><volume>5</volume><fpage>173</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1038/nrn1346</pub-id><pub-id pub-id-type="pmid">14976517</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valakh</surname> <given-names>V</given-names></name><name><surname>Frey</surname> <given-names>E</given-names></name><name><surname>Babetto</surname> <given-names>E</given-names></name><name><surname>Walker</surname> <given-names>LJ</given-names></name><name><surname>DiAntonio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury</article-title><source>Neurobiology of Disease</source><volume>77</volume><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2015.02.014</pub-id><pub-id pub-id-type="pmid">25726747</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Zhan</surname> <given-names>C</given-names></name><name><surname>Ma</surname> <given-names>E</given-names></name><name><surname>Yang</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neurofilament proteins in axonal regeneration and neurodegenerative diseases</article-title><source>Neural Regeneration Research</source><volume>7</volume><elocation-id>620</elocation-id><pub-id pub-id-type="doi">10.3969/j.issn.1673-5374.2012.08.010</pub-id><pub-id pub-id-type="pmid">25745454</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname> <given-names>TA</given-names></name><name><surname>Wang</surname> <given-names>B</given-names></name><name><surname>Huntwork-Rodriguez</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>Z</given-names></name><name><surname>Eastham-Anderson</surname> <given-names>J</given-names></name><name><surname>Modrusan</surname> <given-names>Z</given-names></name><name><surname>Kaminker</surname> <given-names>JS</given-names></name><name><surname>Tessier-Lavigne</surname> <given-names>M</given-names></name><name><surname>Lewcock</surname> <given-names>JW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury</article-title><source>PNAS</source><volume>110</volume><fpage>4039</fpage><lpage>4044</lpage><pub-id pub-id-type="doi">10.1073/pnas.1211074110</pub-id><pub-id pub-id-type="pmid">23431164</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welsbie</surname> <given-names>DS</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name><name><surname>Ge</surname> <given-names>Y</given-names></name><name><surname>Mitchell</surname> <given-names>KL</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Martin</surname> <given-names>SE</given-names></name><name><surname>Berlinicke</surname> <given-names>CA</given-names></name><name><surname>Hackler</surname> <given-names>L</given-names></name><name><surname>Fuller</surname> <given-names>J</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Cao</surname> <given-names>LH</given-names></name><name><surname>Han</surname> <given-names>B</given-names></name><name><surname>Auld</surname> <given-names>D</given-names></name><name><surname>Xue</surname> <given-names>T</given-names></name><name><surname>Hirai</surname> <given-names>S</given-names></name><name><surname>Germain</surname> <given-names>L</given-names></name><name><surname>Simard-Bisson</surname> <given-names>C</given-names></name><name><surname>Blouin</surname> <given-names>R</given-names></name><name><surname>Nguyen</surname> <given-names>JV</given-names></name><name><surname>Davis</surname> <given-names>CH</given-names></name><name><surname>Enke</surname> <given-names>RA</given-names></name><name><surname>Boye</surname> <given-names>SL</given-names></name><name><surname>Merbs</surname> <given-names>SL</given-names></name><name><surname>Marsh-Armstrong</surname> <given-names>N</given-names></name><name><surname>Hauswirth</surname> <given-names>WW</given-names></name><name><surname>DiAntonio</surname> <given-names>A</given-names></name><name><surname>Nickells</surname> <given-names>RW</given-names></name><name><surname>Inglese</surname> <given-names>J</given-names></name><name><surname>Hanes</surname> <given-names>J</given-names></name><name><surname>Yau</surname> <given-names>KW</given-names></name><name><surname>Quigley</surname> <given-names>HA</given-names></name><name><surname>Zack</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death</article-title><source>PNAS</source><volume>110</volume><fpage>4045</fpage><lpage>4050</lpage><pub-id pub-id-type="doi">10.1073/pnas.1211284110</pub-id><pub-id pub-id-type="pmid">23431148</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welsbie</surname> <given-names>DS</given-names></name><name><surname>Mitchell</surname> <given-names>KL</given-names></name><name><surname>Jaskula-Ranga</surname> <given-names>V</given-names></name><name><surname>Sluch</surname> <given-names>VM</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Buehler</surname> <given-names>E</given-names></name><name><surname>Patel</surname> <given-names>A</given-names></name><name><surname>Martin</surname> <given-names>SE</given-names></name><name><surname>Zhang</surname> <given-names>PW</given-names></name><name><surname>Ge</surname> <given-names>Y</given-names></name><name><surname>Duan</surname> <given-names>Y</given-names></name><name><surname>Fuller</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>BJ</given-names></name><name><surname>Hamed</surname> <given-names>E</given-names></name><name><surname>Chamling</surname> <given-names>X</given-names></name><name><surname>Lei</surname> <given-names>L</given-names></name><name><surname>Fraser</surname> <given-names>IDC</given-names></name><name><surname>Ronai</surname> <given-names>ZA</given-names></name><name><surname>Berlinicke</surname> <given-names>CA</given-names></name><name><surname>Zack</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Enhanced functional genomic screening identifies novel mediators of dual leucine zipper Kinase-Dependent injury signaling in neurons</article-title><source>Neuron</source><volume>94</volume><fpage>1142</fpage><lpage>1154</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.008</pub-id><pub-id pub-id-type="pmid">28641113</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>JJ</given-names></name><name><surname>Arancillo</surname> <given-names>M</given-names></name><name><surname>Stay</surname> <given-names>TL</given-names></name><name><surname>George-Jones</surname> <given-names>NA</given-names></name><name><surname>Levy</surname> <given-names>SL</given-names></name><name><surname>Heck</surname> <given-names>DH</given-names></name><name><surname>Sillitoe</surname> <given-names>RV</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cerebellar zonal patterning relies on purkinje cell neurotransmission</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>8231</fpage><lpage>8245</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0122-14.2014</pub-id><pub-id pub-id-type="pmid">24920627</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Wu</surname> <given-names>Z</given-names></name><name><surname>Renier</surname> <given-names>N</given-names></name><name><surname>Simon</surname> <given-names>DJ</given-names></name><name><surname>Uryu</surname> <given-names>K</given-names></name><name><surname>Park</surname> <given-names>DS</given-names></name><name><surname>Greer</surname> <given-names>PA</given-names></name><name><surname>Tournier</surname> <given-names>C</given-names></name><name><surname>Davis</surname> <given-names>RJ</given-names></name><name><surname>Tessier-Lavigne</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pathological axonal death through a MAPK cascade that triggers a local energy deficit</article-title><source>Cell</source><volume>160</volume><fpage>161</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.053</pub-id><pub-id pub-id-type="pmid">25594179</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63509.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Orr</surname><given-names>Harry T</given-names></name><role>Reviewing Editor</role><aff><institution>University of Minnesota</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Le Pichon</surname><given-names>Claire E</given-names></name><role>Reviewer</role><aff><institution>National Institutes of Health</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>In this very nicely revised submission an extensive amount of data are provided supporting the supporting the conclusions drawn regarding the roles of DLK and LZK in the cerebellum. Strengths include use of various Cre-inducible knockout and transgenic mouse lines of DLK and LZK and genetics to compare the role of DLK and LZK in Purkinje cells. Novel findings include that DLK and LZK are dispensable for proper cerebellar Purkinje cell development, and that increased DLK or LZK activity is sufficient to drive Purkinje cell death.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Activation of MAP3K DLK and LZK in Purkinje Cells Causes Rapid and Slow Degeneration Depending on Signaling Strength&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Jonathan Cooper as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Claire E Le Pichon (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>Summary:</p><p>Overall, reviewers found the work in this study to be for the most part well done with a solid set of experiments with the data supporting the conclusions drawn. Strengths include use of various Cre-inducible knockout and transgenic mouse lines of DLK and LZK and genetics to compare the role of DLK and LZK in Purkinje cells. Novel findings include that DLK and LZK are dispensable for proper cerebellar Purkinje cell development, and that increased DLK or LZK activity is sufficient to drive Purkinje cell death. For publication of this manuscript in <italic>eLife</italic>, the following points need to be addressed.</p><p>Essential Revisions:</p><p>1) The authors need to acknowledge and discuss the fact that the Parvalbumin-Cre driver is widely expressed throughout the nervous system. This is an important point for interpretation of the experiments in this paper. While conclusions regarding Purkinje cell-related phenotypes are appropriate, interpretation of phenotypes such as behavior or early mortality is complex.</p><p>Specifically, in the DLK KO experiment, a Parvalbumin-Cre line is crossed to a Dlk flox line to delete DLK in Purkinje neurons, but also deletes DLK in many other neurons that express Parvalbumin during their development. In the over-expression models, the extreme phenotypes observed for body weight and motor behavior phenotypes are unlikely the consequence of Purkinje cell death alone, and this should be discussed.</p><p>2) For Figure 3, can the authors add an example image or close-up to illustrate the quantification in 3F of caspase- and caspase+ dendrite swellings? Please add an explanation of how a dendrite is classified as swollen or not.</p><p>3) Rostral versus caudal PV-Cre; TdT differences in expression in the cerebellum for the LZK OE are interesting; did a similar phenomenon not affect the DLK OE cross? Please comment. If not, does the uneven expression of the LZK OE transgene explain why its phenotype is less severe than the DLK OE? (one can imagine the patchy expression pattern affecting other PV+ neurons in a similar way, so if it was more homogeneous in the DLK OE mouse, this could explain the stronger phenotype and the early death etc).</p><p>4) For the over-expression models, show an image of p-cJun in rest of the brain? This can help support why the animals fail to thrive, and that the transgene effect is not restricted to the cerebellum.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63509.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>1) The authors need to acknowledge and discuss the fact that the Parvalbumin-Cre driver is widely expressed throughout the nervous system. This is an important point for interpretation of the experiments in this paper. While conclusions regarding Purkinje cell-related phenotypes are appropriate, interpretation of phenotypes such as behavior or early mortality is complex.</p><p>Specifically, in the DLK KO experiment, a Parvalbumin-Cre line is crossed to a Dlk flox line to delete DLK in Purkinje neurons, but also deletes DLK in many other neurons that express Parvalbumin during their development. In the over-expression models, the extreme phenotypes observed for body weight and motor behavior phenotypes are unlikely the consequence of Purkinje cell death alone, and this should be discussed.</p></disp-quote><p>We completely agree with the reviewers’ suggestion.</p><p>In the original manuscript, we stated in the first paragraph of the Discussion that “As Purkinje cells and cerebellum are not essential for animal viability, we interpret that the lethality of <italic>Pvalb<sup>Cre/+</sup></italic>;DLK(iOE)/+ pups is likely due to disruption of other parvalbumin-expression neurons, with the underlying basis remaining to be addressed in future studies”.</p><p>In the revised manuscript, we have expanded the Discussion to emphasize that the extreme phenotypes observed for body weight and motor behavior phenotypes in the over-expression mice are unlikely the consequence of Purkinje cell death alone.</p><p>“Additionally, we observed body weight loss, motor deficits and early mortality associated with <italic>Pvalb<sup>Cre/+</sup>;</italic> Hipp11-DLK(iOE<italic>)/+</italic> pups. […] While our data do not address the cellular and/or circuit basis of these gross phenotypes, we infer that the grossly abnormality and lethality of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)<italic>/+</italic> pups are unlikely the consequence of Purkinje cell death alone. The underlying basis would be of interest in future studies.”</p><p>It is our hope that by sharing our observations on these mice, it will stimulate the interests of researchers with proper expertise to investigate the mechanisms at the cellular and circuit levels.</p><disp-quote content-type="editor-comment"><p>2) For Figure 3, can the authors add an example image or close-up to illustrate the quantification in 3F of caspase- and caspase+ dendrite swellings? Please add an explanation of how a dendrite is classified as swollen or not.</p></disp-quote><p>By Calbindin staining, we observed the dendrites of normal Purkinje cells as smooth bush-like arbors. In degenerating Purkinje cells, the dendrites frequently showed numerous varicosities along the arbors, which we annotated as dendrite swellings in Figure 3. We showed an example of swollen dendrites containing cleaved caspase-3<sup>+</sup> signals in the original Figure 3C (the enlarged panels with blue outline). We have now included a new Figure 3—figure supplement 4 showing dendrite swellings that are negative for cleaved caspase-3. We made text revision to explain our classification of dendrite swellings (subsection “Elevated DLK expression disrupts dendritic cytoskeleton”).</p><disp-quote content-type="editor-comment"><p>3) Rostral versus caudal PV-Cre; TdT differences in expression in the cerebellum for the LZK OE are interesting; did a similar phenomenon not affect the DLK OE cross? Please comment. If not, does the uneven expression of the LZK OE transgene explain why its phenotype is less severe than the DLK OE? (one can imagine the patchy expression pattern affecting other PV+ neurons in a similar way, so if it was more homogeneous in the DLK OE mouse, this could explain the stronger phenotype and the early death etc).</p></disp-quote><p>The induced expression patterns from both DLK(iOE) and LZK(iOE) transgenes using the <italic>Pvalb<sup>Cre</sup></italic> were similar, starting stronger in anterior lobules in the cerebellum. This is shown in the revised Figure 2—figure supplement 1D (outlined on the P10 image). The rapid death of Purkinje cells in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ animals makes the pattern of tdTomato expression appearing different from those for <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ (in Figure 4E and Figure 4—figure supplement 1D). We also showed that p-c-Jun levels in Purkinje cells of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ mice were stronger than those in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ mice (see Figure 5—figure supplement 1J, K, L). Therefore, we conclude that the phenotypic differences between <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/<italic>+</italic> are not due to the patchy expression, rather the signaling strength.</p><disp-quote content-type="editor-comment"><p>4) For the over-expression models, show an image of p-cJun in rest of the brain? This can help support why the animals fail to thrive, and that the transgene effect is not restricted to the cerebellum.</p></disp-quote><p>We have included such images showing p-c-Jun in cortex of <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ and <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-LZK(iOE)/+, respectively, in a new Figure 3—figure supplement 1 and a new Figure 4—figure supplement 3. We observed basal levels of p-c-Jun in cells not expressing either kinase and p-c-Jun staining in those marked by tdTomato as induced by elevated DLK or LZK expression.</p><p>As responded to point 1, we agree that the transgene effect is not restricted to the cerebellum. In this manuscript, we have focused our analysis on the effects on cerebellar Purkinje cells. We hope to dissect the underlying basis for other abnormalities in <italic>Pvalb<sup>Cre/+</sup>;</italic>Hipp11-DLK(iOE)/+ in future studies.</p></body></sub-article></article>